Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

All Monthly Communication Reports for Innovative Medicines Canada/Médicaments novateurs Canada

Bettina Hamelin, President (Organization)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results null-null of 963

  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tara Shannon , Assistant Deputy Minister | Environment and Climate Change Canada (ECCC)

    Subject Matter of the communication: Environment, Health, Industry, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Foreign Affairs
    Communication date: 2024-10-16
    Posted date: 2024-11-12
    Communication number: 371-620808 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Luc Thériault, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-10-16
    Posted date: 2024-11-12
    Communication number: 371-620805 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Greg Orencsak, Deputy Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Infrastructure, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Foreign Affairs
    Communication date: 2024-10-15
    Posted date: 2024-11-12
    Communication number: 371-620801 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ben Chin, Senior Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Agriculture, Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-10-07
    Posted date: 2024-11-12
    Communication number: 371-620795 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau , Associate Assistant Deputy Minister | Health Policy Branch | Health Canada (HC)
    • Celia Lourenco, Associate Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
    • Greg Orencsak, Deputy Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Infrastructure, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-10-02
    Posted date: 2024-11-12
    Communication number: 371-620790 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Infrastructure, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Foreign Affairs
    Communication date: 2024-09-26
    Posted date: 2024-10-11
    Communication number: 371-616925 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ehsan Naik, Director of Policy | Office of the Minister of Health | Health Canada (HC)
    • Jade Mallette , Director of Parliamentary Affairs | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Infrastructure, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616911 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jessica Fullerton , Senior Policy Advisor | Office of the Minister of Intergovernmental Affairs | Infrastructure Canada (INFC)

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616901 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Yash Nanda, Deputy Director of Policy to the Deputy Prime Minister and Minister of Finance of Canada | Finance Canada (FIN)

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616885 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Nicholas Kang, Senior Policy Advisor | Policy and Cabinet Affairs | Prime Minister's Office (PMO)

    Subject Matter of the communication: Agriculture, Consumer Issues, Health, Infrastructure, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616884 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ya'ara Saks, Minister of Mental Health and Addictions, and Associate Minister of Health | House of Commons
    • Michelle Boudreau, Associate Assistant Deputy Minister | Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616883 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mohamed-Iqbal Ravalia, Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616880 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marie-Françoise Mégie, Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616877 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Shuvaloy Majumdar, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616874 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Valerie Bradford, Member of Parliament | House of Commons

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616873 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tom Kmiec, Member of Parliament | House of Commons

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Industry, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616872 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chandra Arya, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616870 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Earl Dreeshen, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616867 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Corey Tochor, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616863 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean-Denis Garon, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616861 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bernard Généreux, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616859 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Consumer Issues, Health, Infrastructure, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616856 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alison O'Leary, Senior Assistant Deputy Minister | Infrastructure Canada (INFC)
    • Chris Forbes, Deputy Minister of Finance | Finance Canada (FIN)

    Subject Matter of the communication: Agriculture, Consumer Issues, Health, Infrastructure, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616845 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chris Zhou, Acting Director of Policy to the Minister of Small Business | Innovation, Science and Economic Development Canada (ISED)
    • Rechie Valdez, Minister of Small Business | House of Commons
    • Ajay Rakhra, Senior Advisor, Ontario and Stakeholder Relations to the Minister of Small Business | Innovation, Science and Economic Development Canada (ISED)
    • Christiana Osei, Digital Media and Communications Advisor to Minister of Small Business | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616839 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kim Pate, Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616836 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Peter Fragiskatos, Member of Parliament | House of Commons

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616834 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Francis Scarpaleggia, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Infrastructure, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616830 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Matt Jeneroux, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616827 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tony Baldinelli, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616824 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Helena Jaczek, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616823 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Yasir Naqvi, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616822 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Francesco Sorbara, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616821 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Adam Chambers, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616816 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jamie Kippen, Chief of Staff | Minister's Office | Environment and Climate Change Canada (ECCC)

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-08-13
    Posted date: 2024-09-10
    Communication number: 371-614159 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Harry Orbach-Miller, Policy Advisor and Senior Coordinator | Prime Minister's Office | Prime Minister's Office (PMO)

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-07-24
    Posted date: 2024-08-14
    Communication number: 371-612766 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mark Holland, Minister of Health | Health Canada (HC)
    • Jade Mallette, Director of Parliamentary Affairs, office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Consumer Issues, Health, Industry, Infrastructure, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-07-18
    Posted date: 2024-08-14
    Communication number: 371-612762 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Judith Seidman, Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-06-27
    Posted date: 2024-07-08
    Communication number: 371-609748 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mohamed-Iqbal Ravalia, Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-06-19
    Posted date: 2024-07-08
    Communication number: 371-609747 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gary Vidal, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-06-13
    Posted date: 2024-07-08
    Communication number: 371-609746 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rosemary Moodie , Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-06-12
    Posted date: 2024-07-08
    Communication number: 371-609745 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Geneviève Lévesque, Senior Parliamentary and Legal Affairs Advisor | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-06-10
    Posted date: 2024-07-08
    Communication number: 371-609743 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Randy Hoback, Member of Parliament | House of Commons

    Subject Matter of the communication: Agriculture, Consumer Issues, Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, Research and Development, Foreign Affairs
    Communication date: 2024-06-07
    Posted date: 2024-07-08
    Communication number: 371-609739 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy , Deputy Minister, Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-05-28
    Posted date: 2024-06-14
    Communication number: 371-607914 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Max Valiquette, Executive Director of Communications | Prime Minister's Office (PMO)

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-05-23
    Posted date: 2024-06-14
    Communication number: 371-607903 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons
    • Tom Kmiec, Member of Parliament | House of Commons
    • Blaine Calkins, Member of Parliament | House of Commons
    • Earl Dreeshen, Member of Parliament | House of Commons

    Subject Matter of the communication: Agriculture, Consumer Issues, Health, Industry, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-05-23
    Posted date: 2024-06-14
    Communication number: 371-607870 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Desiree Sam, Parliamentary Secretary Assistant | Health Canada (HC)
    • Yasir Naqvi, Member of Parliament, Parliamentary Secretary to the Minister of Health | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-05-07
    Posted date: 2024-06-14
    Communication number: 371-607833 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau, Associate Assistant Deputy Minister | Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-05-06
    Posted date: 2024-06-14
    Communication number: 371-607796 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Étienne-René Massie, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Andrea Johnston, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Francis Bilodeau, Associate Deputy Minister | Office of the Associate Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Infrastructure, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-04-15
    Posted date: 2024-05-14
    Communication number: 371-603406 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Brian Masse, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Infrastructure, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Foreign Affairs
    Communication date: 2024-04-15
    Posted date: 2024-05-14
    Communication number: 371-603374 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mark Schaan, Senior Assistant Deputy Minister | Strategy and Innovation Policy Sector - Assistant Deputy Minister's Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Infrastructure, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-04-15
    Posted date: 2024-05-14
    Communication number: 371-603002 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2024-03-01
    Posted date: 2024-04-12
    Communication number: 371-599744 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau, Associate Assistant Deputy Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2024-01-18
    Posted date: 2024-02-12
    Communication number: 371-592324 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister of Health | Health Canada (HC)
    • Michelle Boudreau, Associate Assistant Deputy Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2024-01-11
    Posted date: 2024-02-12
    Communication number: 371-592323 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stefania Trombetti, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2024-01-05
    Posted date: 2024-02-12
    Communication number: 371-592322 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jennifer Miller , Assistant Secretary | Privy Council Office (PCO)

    Subject Matter of the communication: Health
    Communication date: 2023-12-12
    Posted date: 2024-01-15
    Communication number: 371-590461 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister of Health | Health Canada (HC)
    • Christopher Johnstone, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-12-12
    Posted date: 2024-01-15
    Communication number: 371-590458 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ehsan Naik, Director of Policy | Office of the Minister of Health | Health Canada (HC)
    • Jean-Sebastien Bock, Deputy Chief of Staff | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-12-12
    Posted date: 2024-01-15
    Communication number: 371-590453 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ehsan Naik , Director of Policy | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-12-08
    Posted date: 2024-01-15
    Communication number: 371-590449 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Simon Kennedy , Deputy Minister, Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2023-11-08
    Posted date: 2023-12-08
    Communication number: 371-586195 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sébastien Lemire, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-11-08
    Posted date: 2023-12-08
    Communication number: 371-586192 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sarah Polowin, Director of Parliamentary Affairs | Senate of Canada
    • Mohamed-Iqbal Ravalia, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-11-08
    Posted date: 2023-12-08
    Communication number: 371-586187 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gigi Osler, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-11-08
    Posted date: 2023-12-08
    Communication number: 371-586184 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Layla Platt, Executive Assistant | Employment and Social Development Canada (ESDC)
    • Christopher Evelyn, Chief of Staff to the Minister of Families, Children & Social Development | Employment and Social Development Canada (ESDC)

    Subject Matter of the communication: Health, Industry, Science and Technology, Small Business
    Communication date: 2023-11-07
    Posted date: 2023-12-08
    Communication number: 371-586164 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Corey Tochor, Member of Parliament | House of Commons
    • James Hawkes, Parliamentary Assistant | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-11-07
    Posted date: 2023-12-08
    Communication number: 371-586151 (amended from 371-586101) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ehsan Naik , Director of Policy | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-11-07
    Posted date: 2023-12-08
    Communication number: 371-586146 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rechie Valdez, Member of Parliament and Minister of Small Business | House of Commons
    • Chris Zhou, Senior Policy and Atlantic Advisor | Office of the Minister of Small Business | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Small Business
    Communication date: 2023-11-07
    Posted date: 2023-12-08
    Communication number: 371-586130 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Francis Scarpaleggia, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-11-07
    Posted date: 2023-12-08
    Communication number: 371-586128 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jeff Warning, Associate Assistant Secretary | Privy Council Office (PCO)
    • Jennifer Miller , Assistant Secretary | Privy Council Office (PCO)
    • Alexis Conrad, Assistant Secretary to the Cabinet | Privy Council Office (PCO)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-11-07
    Posted date: 2023-12-08
    Communication number: 371-586117 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sharon Burey, Senator | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2023-11-07
    Posted date: 2023-12-08
    Communication number: 371-586113 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jessica LaForge, Policy Advisor | Pacific Economic Development Canada (PacifiCan)
    • Gurjiven Sandhu, Director of Policy | Pacific Economic Development Canada (PacifiCan)

    Subject Matter of the communication: Health, Regional Development, Science and Technology
    Communication date: 2023-11-07
    Posted date: 2023-12-08
    Communication number: 371-586102 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marie-Françoise Mégie, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-11-07
    Posted date: 2023-12-08
    Communication number: 371-586099 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Robert Kitchen, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2023-11-07
    Posted date: 2023-12-08
    Communication number: 371-586091 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Luc Thériault, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-11-07
    Posted date: 2023-12-08
    Communication number: 371-586080 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Helena Jaczek, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2023-11-07
    Posted date: 2023-12-08
    Communication number: 371-586078 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Ellis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-11-06
    Posted date: 2023-12-08
    Communication number: 371-586072 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ben Chin, Senior Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2023-11-06
    Posted date: 2023-12-08
    Communication number: 371-586070 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stan Kutcher, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-11-06
    Posted date: 2023-12-08
    Communication number: 371-586068 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Yash Nanda, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health
    Communication date: 2023-11-06
    Posted date: 2023-12-08
    Communication number: 371-586064 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Francesco Sorbara, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-11-06
    Posted date: 2023-12-08
    Communication number: 371-586062 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Andrew Cardozo, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-11-06
    Posted date: 2023-12-08
    Communication number: 371-586061 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Josh Dadjo, Director of Parliamentary Affairs | Senate of Canada

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2023-11-06
    Posted date: 2023-12-08
    Communication number: 371-586060 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chandra Arya, Member of the House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-11-06
    Posted date: 2023-12-08
    Communication number: 371-586059 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Carol Hughes, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-11-06
    Posted date: 2023-12-08
    Communication number: 371-586058 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Suzy McDonald, Associate Deputy Minister | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2023-11-06
    Posted date: 2023-12-08
    Communication number: 371-586056 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Valerie Bradford, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-11-06
    Posted date: 2023-12-08
    Communication number: 371-586054 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pamela Aung-Thin , Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
    • Dr. Stephen Lucas, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-11-06
    Posted date: 2023-12-08
    Communication number: 371-586045 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eshan Naik, Director of Policy | Office of the Minister of Health | Health Canada (HC)
    • Ophelia John , Senior Policy Advisor | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-11-01
    Posted date: 2023-12-08
    Communication number: 371-586039 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stefania Trombetti, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-10-05
    Posted date: 2023-11-10
    Communication number: 371-581897 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean Sebastien Bock, Deputy Chief of Staff | Office of the Minister of Health | Health Canada (HC)
    • Ophelia John, Senior Policy Advisor | Office of the Minister of Health | Health Canada (HC)
    • Mark Holland, Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-10-04
    Posted date: 2023-11-10
    Communication number: 371-581895 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-09-21
    Posted date: 2023-10-11
    Communication number: 371-578169 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pamela Aung-Thin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-09-14
    Posted date: 2023-10-11
    Communication number: 371-578162 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Nancy Hamzawi, Executive Vice-President | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-08-23
    Posted date: 2023-09-14
    Communication number: 371-576312 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy , Deputy Minister, Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-08-23
    Posted date: 2023-09-14
    Communication number: 371-576311 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Yash Nanda, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health, Taxation and Finance
    Communication date: 2023-08-10
    Posted date: 2023-09-14
    Communication number: 371-576310 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Susan Fitzpatrick, CEO | Canadian Drug Agency Transition Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-08-02
    Posted date: 2023-09-14
    Communication number: 371-576309 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stefania Trombetti, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-08-01
    Posted date: 2023-09-14
    Communication number: 371-576306 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Thomas Digby, Chairperson | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2023-07-21
    Posted date: 2023-08-01
    Communication number: 371-573724 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-07-18
    Posted date: 2023-08-01
    Communication number: 371-573723 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bianca Hossain, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-07-12
    Posted date: 2023-08-01
    Communication number: 371-573722 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba , Deputy Director of Policy | Health Canada (HC)
    • Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-07-05
    Posted date: 2023-08-01
    Communication number: 371-573721 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stan Kutcher, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-06-28
    Posted date: 2023-07-07
    Communication number: 371-571197 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stefania Trombetti, Assistant Deputy Minister | Health Canada (HC)
    • Jean-Yves Duclos, Minister of Health | Health Canada (HC)
    • Sandenga Yeba , Deputy Director of Policy | Health Canada (HC)
    • Stephen Lucas, Deputy Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-06-16
    Posted date: 2023-07-07
    Communication number: 371-571196 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Susan Fitzpatrick, CEO | Canadian Drug Agency Transition Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-06-08
    Posted date: 2023-07-07
    Communication number: 371-571195 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba , Deputy Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-05-30
    Posted date: 2023-06-12
    Communication number: 371-568023 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Office of Life Sciences and Biomanufacturing Readiness (OLSBR) | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-05-23
    Posted date: 2023-06-12
    Communication number: 371-568013 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Connor MacDonald , Policy Advisor, Office of the Leader of the Opposition | House of Commons
    • Shawn Driscoll, Stakeholder Relations Advisor, Office of the Leader of the Opposition | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2023-05-05
    Posted date: 2023-06-12
    Communication number: 371-568009 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy , Deputy Minister, Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-05-03
    Posted date: 2023-06-12
    Communication number: 371-568011 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2023-04-26
    Posted date: 2023-05-05
    Communication number: 371-564136 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2023-04-24
    Posted date: 2023-05-05
    Communication number: 371-564134 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jocelyne Voisin, Assistant Deputy Minister | Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-04-24
    Posted date: 2023-05-05
    Communication number: 371-564133 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stefania Trombetti, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-04-24
    Posted date: 2023-05-05
    Communication number: 371-564132 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-04-19
    Posted date: 2023-05-05
    Communication number: 371-564131 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy , Deputy Minister, Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2023-02-20
    Posted date: 2023-03-14
    Communication number: 371-559157 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba , Deputy Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-02-13
    Posted date: 2023-03-14
    Communication number: 371-559149 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Flordeliz (Gigi) Osler , Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2023-02-09
    Posted date: 2023-03-14
    Communication number: 371-559131 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-01-27
    Posted date: 2023-02-13
    Communication number: 371-555742 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)
    • Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-01-16
    Posted date: 2023-02-13
    Communication number: 371-555736 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Patrick Cousineau, Member's Assistant, Office of MP Greg McLean | House of Commons
    • Bradley Bekkeheim, Member's Assistant, Office of MP Damien Kurek | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2023-01-11
    Posted date: 2023-02-13
    Communication number: 371-555730 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-12-21
    Posted date: 2023-01-10
    Communication number: 371-553045 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Majid Jowhari, Member of Parliament | House of Commons
    • Banafsheh Shamdani, Parliamentary Assistant | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-12-16
    Posted date: 2023-01-10
    Communication number: 371-553043 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, Intellectual Property
    Communication date: 2022-12-16
    Posted date: 2023-01-10
    Communication number: 371-553041 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-12-15
    Posted date: 2023-01-10
    Communication number: 371-553040 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mohamed-Iqbal Ravalia, Senator | Senate of Canada
    • Sarah Polowin, Director of Parliamentary Affairs | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2022-12-13
    Posted date: 2023-01-10
    Communication number: 371-553037 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Iqwinder Gaheer, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2022-12-13
    Posted date: 2023-01-10
    Communication number: 371-553036 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Susan Fitzpatrick, CEO | Canadian Drug Agency Transition Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-12-13
    Posted date: 2023-01-10
    Communication number: 371-553035 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Judy Sgro, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-12-08
    Posted date: 2023-01-10
    Communication number: 371-553034 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Luc Thériault, Member of Parliament | House of Commons
    • Ariane Venne-Hébert, Constituency Assistant | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-12-05
    Posted date: 2023-01-10
    Communication number: 371-553033 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Francesco Sorbara, Member of Parliment | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-12-05
    Posted date: 2023-01-10
    Communication number: 371-553031 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean-Sebastien Bock, Director of Policy | Office of the Minister of Health | Health Canada (HC)
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)
    • Jamie Kippen, Chief of Staff to the Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-12-01
    Posted date: 2023-01-10
    Communication number: 371-553020 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chris Zhou, Policy Advisor | Health Canada (HC)

    Subject Matter of the communication: Intellectual Property, International Trade, Science and Technology
    Communication date: 2022-11-18
    Posted date: 2022-12-14
    Communication number: 371-550522 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-10-21
    Posted date: 2022-11-09
    Communication number: 371-545699 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-09-21
    Posted date: 2022-10-11
    Communication number: 371-542926 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Susan Fitzpatrick, CEO | Canadian Drug Agency Transition Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-08-31
    Posted date: 2022-09-07
    Communication number: 371-540839 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Michael Brewster, Director of Policy | Environment and Climate Change Canada (ECCC)
    • Kathleen Legault-Meek , Director of Parliamentary Affairs | Environment and Climate Change Canada (ECCC)

    Subject Matter of the communication: Environment, Health, Industry, Science and Technology
    Communication date: 2022-08-30
    Posted date: 2022-09-07
    Communication number: 371-540838 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-08-15
    Posted date: 2022-09-07
    Communication number: 371-540837 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, Intellectual Property, International Trade
    Communication date: 2022-08-12
    Posted date: 2022-09-07
    Communication number: 371-540834 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Laurence Harvey , Senior Policy Advisor | Global Affairs Canada (GAC)

    Subject Matter of the communication: Intellectual Property, International Trade, Science and Technology
    Communication date: 2022-07-18
    Posted date: 2022-08-12
    Communication number: 371-539643 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-07-15
    Posted date: 2022-08-12
    Communication number: 371-539637 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy , Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2022-06-28
    Posted date: 2022-07-14
    Communication number: 371-537607 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Nancy Hamzawi, Federal Lead and Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2022-06-27
    Posted date: 2022-07-14
    Communication number: 371-537606 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, International Trade
    Communication date: 2022-06-16
    Posted date: 2022-07-14
    Communication number: 371-537605 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean-Sebastien Bock, Director of Policy | Office of the Minister of Health | Health Canada (HC)
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-06-09
    Posted date: 2022-07-14
    Communication number: 371-537609 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ed Morgan , Director General | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-05-31
    Posted date: 2022-06-20
    Communication number: 371-536049 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ajay Rakhra , Chief of Staff | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-05-16
    Posted date: 2022-06-08
    Communication number: 371-533581 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy - , Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, International Trade, Science and Technology
    Communication date: 2022-05-06
    Posted date: 2022-06-08
    Communication number: 371-533586 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas , Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-05-06
    Posted date: 2022-06-08
    Communication number: 371-533583 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Daniel Saad, A/Director of Policy | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-05-06
    Posted date: 2022-06-08
    Communication number: 371-533580 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Senior Policy Advisor | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-04-25
    Posted date: 2022-05-11
    Communication number: 371-531067 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Luc Thériault, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-04-22
    Posted date: 2022-05-11
    Communication number: 371-531063 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean-sebastien Bock , Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-04-19
    Posted date: 2022-05-11
    Communication number: 371-531072 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Zachary Nixon , Senior Special Assistant Stakeholder Relations and Regional Affairs | Global Affairs Canada (GAC)
    • Jillian White, Director of Policy | Global Affairs Canada (GAC)
    • Laurence Harvey , Senior Policy Advisor | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2022-03-18
    Posted date: 2022-04-13
    Communication number: 371-528613 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eric Belair , Associate Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-03-07
    Posted date: 2022-04-13
    Communication number: 371-528617 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Susan Fitzpatrick, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-02-23
    Posted date: 2022-03-11
    Communication number: 371-524978 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-02-15
    Posted date: 2022-03-11
    Communication number: 371-524975 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy , Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, Intellectual Property
    Communication date: 2022-02-15
    Posted date: 2022-03-11
    Communication number: 371-524974 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hamzawi Nancy , Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-02-11
    Posted date: 2022-03-11
    Communication number: 371-524967 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jessica Fullerton , Policy Advisor | Office of the Minister of Intergovernmental Affairs, Infrastructure and Communities | Infrastructure Canada (INFC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-02-10
    Posted date: 2022-03-11
    Communication number: 371-525014 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rebecca Caldwell , Senior Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-02-04
    Posted date: 2022-03-11
    Communication number: 371-525007 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-02-01
    Posted date: 2022-03-11
    Communication number: 371-524964 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean- Sebastien Bock, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-01-17
    Posted date: 2022-02-11
    Communication number: 371-521835 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rechie Valdez , Member of Parliament | House of Commons
    • Ajay Rakhra , Chief of Staff | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-01-11
    Posted date: 2022-02-11
    Communication number: 371-521827 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alex MacDonald, Policy Advisor, Health, Office of the Leader of the Opposition | House of Commons
    • Holly Duggan, Director of Outreach and Stakeholder Relations | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-12-15
    Posted date: 2022-01-13
    Communication number: 371-519439 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy , Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry
    Communication date: 2021-12-10
    Posted date: 2022-01-13
    Communication number: 371-519429 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Leslyn Lewis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-12-09
    Posted date: 2022-01-13
    Communication number: 371-519438 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Nancy Hamzawi, Federal Lead and Assistant Deputy Minister | Health Canada (HC)
    • Eric Belair , Associate Assistant Deputy Minister | Health Canada (HC)
    • Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-12-03
    Posted date: 2022-01-13
    Communication number: 371-519426 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steven Outhouse , Deputy Chief of Staff, Office of the Leader of the Official Opposition | House of Commons

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2021-12-02
    Posted date: 2022-01-13
    Communication number: 371-519440 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Elliott Lockington , Chief of Staff | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-12-02
    Posted date: 2022-01-13
    Communication number: 371-519437 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean-Yves Duclos , Minister of Health | Health Canada (HC)
    • Jean-Sébastien Bock, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-12-02
    Posted date: 2022-01-13
    Communication number: 371-519419 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean-Sébastien Bock , Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2021-12-01
    Posted date: 2022-01-13
    Communication number: 371-519434 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean-Sébastien Bock, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-11-26
    Posted date: 2021-12-03
    Communication number: 371-516520 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dylan Marando, Senior Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-11-26
    Posted date: 2021-12-03
    Communication number: 371-516518 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-11-26
    Posted date: 2021-12-03
    Communication number: 371-516513 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Brandan Rowe, Director of Strategic Planning | Privy Council Office (PCO)
    • Dominic LeBlanc, Minister of Intergovernmental Affairs, Infrastructure and Communities | House of Commons
    • Kevin Lavigne, Minister’s Office Deputy Chief of Staff | Privy Council Office (PCO)

    Subject Matter of the communication: Health, Industry, Infrastructure, Regional Development, Science and Technology
    Communication date: 2021-11-12
    Posted date: 2021-12-03
    Communication number: 371-516517 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stan Kutcher, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Infrastructure, Regional Development, Science and Technology
    Communication date: 2021-11-11
    Posted date: 2021-12-03
    Communication number: 371-516515 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2021-11-05
    Posted date: 2021-12-03
    Communication number: 371-516512 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Susan Fitzpatrick, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-10-15
    Posted date: 2021-11-05
    Communication number: 371-515089 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-08-17
    Posted date: 2021-09-08
    Communication number: 371-513703 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eric Belair, Associate Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-08-11
    Posted date: 2021-09-08
    Communication number: 371-513702 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-07-30
    Posted date: 2021-09-08
    Communication number: 371-513704 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jason Easton, Chief of Staff | Minister of International Trade | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, International Trade, Science and Technology
    Communication date: 2021-07-21
    Posted date: 2021-07-30
    Communication number: 371-511931 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-07-21
    Posted date: 2021-07-30
    Communication number: 371-511930 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-07-19
    Posted date: 2021-07-30
    Communication number: 371-511932 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Erin O'Toole, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-06-21
    Posted date: 2021-07-13
    Communication number: 371-510206 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Susan Fitzpatrick, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-06-18
    Posted date: 2021-11-05
    Communication number: 371-515090 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2021-06-18
    Posted date: 2021-07-13
    Communication number: 371-510209 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Terry Duguid, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-06-10
    Posted date: 2021-07-13
    Communication number: 371-510200 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-06-08
    Posted date: 2021-07-13
    Communication number: 371-510207 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tom Kmiec, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-06-01
    Posted date: 2021-07-13
    Communication number: 371-510204 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Luc Thériault, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-05-30
    Posted date: 2021-06-14
    Communication number: 371-507810 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chris D’Entremont, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-05-28
    Posted date: 2021-06-14
    Communication number: 371-507809 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Francesco Sorbara, Member of Parliment | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-05-20
    Posted date: 2021-06-14
    Communication number: 371-507803 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ali Ehsassi, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-05-20
    Posted date: 2021-06-14
    Communication number: 371-507802 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Assistant Deputy Minister | Trade Policy and Negotiations | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2021-05-14
    Posted date: 2021-06-14
    Communication number: 371-507811 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mary Ng, Minister of Small Business, Export Promotion and International Trade | Global Affairs Canada (GAC)
    • Jason Easton, Chief of Staff | Minister of International Trade | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry, International Trade, Science and Technology
    Communication date: 2021-05-12
    Posted date: 2021-06-14
    Communication number: 371-507801 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • James Cumming, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2021-05-04
    Posted date: 2021-06-14
    Communication number: 371-507805 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chris d'Entremont, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-04-29
    Posted date: 2021-05-14
    Communication number: 371-504761 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alexandre Deslongchamps, Deputy Chief of Staff / Director of Operations | Natural Resources Canada (NRCan)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-04-29
    Posted date: 2021-05-12
    Communication number: 371-504215 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • François-Philippe Champagne, Minister | Innovation, Science and Economic Development Canada (ISED)
    • Amanda Woodley, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2021-04-29
    Posted date: 2021-05-12
    Communication number: 371-504182 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rob Moore, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-04-27
    Posted date: 2021-05-14
    Communication number: 371-504775 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Andy Fillmore, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-04-22
    Posted date: 2021-05-14
    Communication number: 371-504752 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sean Fraser, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-04-16
    Posted date: 2021-05-14
    Communication number: 371-504745 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pierre Paul-Hus, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-04-16
    Posted date: 2021-05-14
    Communication number: 371-504735 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tracy Gray, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2021-04-14
    Posted date: 2021-05-14
    Communication number: 371-504742 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mark Strahl, Member of Parliament | House of Commons
    • Dan Albas, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-04-09
    Posted date: 2021-05-14
    Communication number: 371-504784 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Patrick Weiler, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-04-09
    Posted date: 2021-05-14
    Communication number: 371-504682 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marcel Saulnier, Associate ADM | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-04-09
    Posted date: 2021-05-12
    Communication number: 371-504188 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Francesco Sorbara, Member of Parliment | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-04-06
    Posted date: 2021-05-14
    Communication number: 371-504797 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gérard Deltell, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-03-31
    Posted date: 2021-04-08
    Communication number: 371-500871 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Luc Thériault, Member of Parliament | House of Commons
    • Julie Vignola, Member of Parliament | House of Commons
    • Mario Simard, Member of Parliament | House of Commons
    • Sébastien Lemire, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-03-30
    Posted date: 2021-04-08
    Communication number: 371-500873 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Luc Thériault, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-03-19
    Posted date: 2021-04-08
    Communication number: 371-500868 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2021-03-19
    Posted date: 2021-04-08
    Communication number: 371-500864 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sabina Saini, Chief of Staff | Health Canada (HC)
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-03-16
    Posted date: 2021-04-08
    Communication number: 371-500866 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stevie O'brien, Chief of Staff | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement, Health
    Communication date: 2021-02-18
    Posted date: 2021-03-05
    Communication number: 371-497400 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stevie O'brien, Chief of Staff | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement, Health
    Communication date: 2021-02-17
    Posted date: 2021-03-05
    Communication number: 371-497399 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-02-11
    Posted date: 2021-03-05
    Communication number: 371-497398 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Luc Thériault, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-01-29
    Posted date: 2021-02-10
    Communication number: 371-494745 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-01-21
    Posted date: 2021-02-10
    Communication number: 371-494744 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jason Easton, Chief of Staff | Minister of Small Business, Export Promotion and International Trade | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-01-20
    Posted date: 2021-02-10
    Communication number: 371-494743 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Greg Fergus, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-01-18
    Posted date: 2021-02-10
    Communication number: 371-494741 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Amanda Woodley, Special Assistant (Policy)/Assistant (Parliamentary Secretary) | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-01-15
    Posted date: 2021-02-10
    Communication number: 371-494738 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marcel Saulnier, Associate Deputy Minister | Canada Drug Agency | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-01-15
    Posted date: 2021-02-10
    Communication number: 371-494732 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hendrik Brakel, Director of Policy | Office of the Leader of the Opposition, MP Erin O’Toole | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-01-07
    Posted date: 2021-02-10
    Communication number: 371-494734 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marcel Saulnier, Associate Deputy Minister | Canada Drug Agency | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-01-06
    Posted date: 2021-02-10
    Communication number: 371-494729 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Robert Oliphant, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2020-12-22
    Posted date: 2021-01-11
    Communication number: 371-492562 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Erin O’Toole, Member of Parliament | House of Commons
    • Michelle Rempel Garner, Member of Parliament | House of Commons
    • Karina Rolland, Manager Stakeholder Relations | House of Commons
    • Matthew Solheim, Policy Advisor | House of Commons
    • Hendrik Brakel, Senior Policy Advisor | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2020-12-08
    Posted date: 2021-01-11
    Communication number: 371-492563 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Christopher d'Entremont, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2020-11-24
    Posted date: 2020-12-11
    Communication number: 371-489942 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Boyan Gerasimov, Director of Policy | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2020-11-10
    Posted date: 2020-12-11
    Communication number: 371-489938 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Luc Thériault, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2020-10-16
    Posted date: 2020-11-10
    Communication number: 371-486481 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Patty Hajdu, Minister of Health | Health Canada (HC)
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2020-10-16
    Posted date: 2020-11-10
    Communication number: 371-486477 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chris d'Entremont, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2020-10-06
    Posted date: 2020-11-10
    Communication number: 371-486479 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sabina Saini, Chief of Staff | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-10-01
    Posted date: 2020-10-26
    Communication number: 371-485638 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Luc Thériault, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2020-09-28
    Posted date: 2020-10-09
    Communication number: 371-483679 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-09-08
    Posted date: 2020-10-09
    Communication number: 371-483682 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sabina Saini, Chief of Staff | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-08-26
    Posted date: 2020-09-03
    Communication number: 371-480990 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2020-07-20
    Posted date: 2020-08-10
    Communication number: 371-479133 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Halucha, Assistant Secretary to the Cabinet | Privy Council Office (PCO)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-07-18
    Posted date: 2020-08-10
    Communication number: 371-479134 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sabina Saini, Chief of Staff | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-07-07
    Posted date: 2020-08-10
    Communication number: 371-479131 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ali Ehsassi, Member of Parliament | House of Commons
    • Sean O’Neill, Parliamentary Secretary Assistan | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2020-06-30
    Posted date: 2020-07-13
    Communication number: 371-477082 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Luc Thériault, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2020-06-04
    Posted date: 2020-07-13
    Communication number: 371-477079 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ian McKay, CEO Invest in Canada | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-05-08
    Posted date: 2020-06-09
    Communication number: 371-474599 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Anil Arora, Chief Statistician of Canada | Statistics Canada (StatCan)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-05-08
    Posted date: 2020-06-09
    Communication number: 371-474598 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mike Kelloway, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2020-04-30
    Posted date: 2020-05-11
    Communication number: 371-472187 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tracy Gray, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Internal Trade, International Trade
    Communication date: 2020-04-08
    Posted date: 2020-05-11
    Communication number: 371-472191 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sabina Saini, Chief of Staff | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2020-04-03
    Posted date: 2020-05-11
    Communication number: 371-472189 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-03-21
    Posted date: 2020-04-14
    Communication number: 371-470393 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-03-19
    Posted date: 2020-04-14
    Communication number: 371-470388 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Amanda Woodley, Parliamentary Secretary Assistant | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Government Procurement, Health, Industry, Internal Trade, International Trade, Science and Technology
    Communication date: 2020-03-18
    Posted date: 2020-04-14
    Communication number: 371-470349 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jeremy Liedtke, Member Assistant, Office of Hon. Pierre Poilievre - MP | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2020-03-16
    Posted date: 2020-04-14
    Communication number: 371-470380 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mike Kelloway, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2020-03-12
    Posted date: 2020-04-14
    Communication number: 371-470376 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Vincent Garneau, Director of Policy | Deputy Prime Minister and Minister of Intergovernmental Affair | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2020-03-11
    Posted date: 2020-04-14
    Communication number: 371-470358 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Greg Fergus, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-03-05
    Posted date: 2020-04-14
    Communication number: 371-470382 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sabina Saini, Chief of Staff | Health Minister’s Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-03-05
    Posted date: 2020-04-14
    Communication number: 371-470339 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mike Kelloway, Member of Parliament, House of Common | House of Commons

    Subject Matter of the communication: Education, Health, Infrastructure, Regional Development, Science and Technology, Small Business, Tourism
    Communication date: 2020-03-04
    Posted date: 2020-04-14
    Communication number: 371-470374 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tina Green, Assistant Secretary, Regulatory Affairs | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-02-28
    Posted date: 2020-03-10
    Communication number: 371-466554 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-02-26
    Posted date: 2020-03-10
    Communication number: 371-466556 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Matt Jeneroux, Member of Parliament and Health Critic | House of Commons
    • Lindsay Keeley, Advisor to Mr. Jeneroux | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2020-02-26
    Posted date: 2020-03-10
    Communication number: 371-466552 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dennis Dawson, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2020-02-19
    Posted date: 2020-03-10
    Communication number: 371-466549 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Marcel Saulnier, Associate ADM | House of Commons
    • Kendal Weber, Associate Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2020-01-29
    Posted date: 2020-02-14
    Communication number: 371-463180 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-01-28
    Posted date: 2020-02-13
    Communication number: 371-464292 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bill Morneau, Minister of Finance | Finance Canada (FIN)
    • Elder Marques, Chief of Staff to Minister Morneau | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2020-01-24
    Posted date: 2020-02-13
    Communication number: 371-464296 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ryan Dunn, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, International Relations, Science and Technology
    Communication date: 2020-01-15
    Posted date: 2020-02-13
    Communication number: 371-464293 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marcel Saulnier, Associate ADM | Health Canada (HC)

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2020-01-09
    Posted date: 2020-02-14
    Communication number: 371-464429 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-12-12
    Posted date: 2020-01-08
    Communication number: 371-462243 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marilyn Gladu, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2019-12-12
    Posted date: 2020-01-08
    Communication number: 371-462242 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pierre Poilievre, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-11-28
    Posted date: 2020-01-08
    Communication number: 371-462239 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2019-09-06
    Posted date: 2019-10-09
    Communication number: 371-459961 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Arif Virani, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-08-27
    Posted date: 2019-09-23
    Communication number: 371-459845 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marcel Saulnier, Associate ADM | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2019-08-15
    Posted date: 2019-09-12
    Communication number: 371-459435 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Caroline Séguin, Director of Policy | Office of the Minister of Tourism, Official Languages and La Francophonie | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology, Small Business
    Communication date: 2019-07-30
    Posted date: 2019-07-31
    Communication number: 371-458028 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dominic Cormier, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Internal Trade, Science and Technology
    Communication date: 2019-07-23
    Posted date: 2019-07-31
    Communication number: 371-458018 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pierre Sabourin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
    • Stefania Trombetti, Acting Assistant Deputy Minister | Regulatory, Operations and Enforcement Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, International Trade
    Communication date: 2019-07-17
    Posted date: 2019-07-31
    Communication number: 371-458023 (amended from 371-458016) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tom Kmiec, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-07-15
    Posted date: 2019-07-31
    Communication number: 371-458022 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2019-07-11
    Posted date: 2019-07-31
    Communication number: 371-458020 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, International Relations
    Communication date: 2019-07-05
    Posted date: 2019-07-31
    Communication number: 371-458019 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mathew Clancy -, Press Secretary, Shadow Cabinet | House of Commons Party Officers | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2019-06-20
    Posted date: 2019-11-28
    Communication number: 371-460934 (amended from 371-457004) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Benjamin Martin, Member's Assistant | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-06-18
    Posted date: 2019-07-11
    Communication number: 371-457006 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-06-18
    Posted date: 2019-07-11
    Communication number: 371-457005 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Benjamin Martin, Member's Assistant | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-06-14
    Posted date: 2019-07-11
    Communication number: 371-457007 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Greg Fergus, MP for Hull-Aylmer, Parliamentary Secretary to the President of the Treasury Board and Minister of Digital Government | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2019-05-30
    Posted date: 2019-06-12
    Communication number: 371-454915 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sébastien Beaupré-Huot, Special Assistant, Operations and Stakeholder Relations Coordination | Employment and Social Development Canada (ESDC)
    • Dylan Marando, Director of Policy | Employment and Social Development Canada (ESDC)

    Subject Matter of the communication: Health, Industry, Labour, Science and Technology
    Communication date: 2019-05-29
    Posted date: 2019-06-12
    Communication number: 371-454898 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Julia Van Drie, Special Assistant (Policy) | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology, Small Business
    Communication date: 2019-05-16
    Posted date: 2019-06-12
    Communication number: 371-454899 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Assistant Deputy Minister | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, International Trade
    Communication date: 2019-05-13
    Posted date: 2019-06-12
    Communication number: 371-454895 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tina Green, Assistant Secretary, Regulatory Affairs | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-05-06
    Posted date: 2019-06-12
    Communication number: 371-454897 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Francesco Sorbara, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-04-30
    Posted date: 2019-05-14
    Communication number: 371-452076 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Michelle Kovacevic, Assistant Deputy Minister | Federal-Provincial Relations and Social Policy Branch | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-04-26
    Posted date: 2019-05-14
    Communication number: 371-452071 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2019-04-25
    Posted date: 2019-05-14
    Communication number: 371-452062 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jamie Innes, Chief of Staff | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, International Trade, Science and Technology
    Communication date: 2019-04-17
    Posted date: 2019-05-14
    Communication number: 371-452245 (amended from 371-452225) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Taras Zalusky, Director Policy, Procurement and Parliamentary affairs | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-04-16
    Posted date: 2019-05-14
    Communication number: 371-452055 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-04-11
    Posted date: 2019-05-14
    Communication number: 371-452050 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kate Proctor, Policy Advisor | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2019-04-08
    Posted date: 2019-05-14
    Communication number: 371-452222 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Halucha, Assistant Secretary to the Cabinet | Privy Council Office (PCO)

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-04-05
    Posted date: 2019-05-14
    Communication number: 371-452043 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-04-04
    Posted date: 2019-05-14
    Communication number: 371-452034 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Robertson, Director of Policy | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, Small Business
    Communication date: 2019-03-26
    Posted date: 2019-04-11
    Communication number: 371-449363 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Health Canada (HC)
    • Abby Hoffman, Assistant Deputy Minister | Strategic Policy | Health Canada (HC)
    • Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Paul Thompson, Associate Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2019-03-18
    Posted date: 2019-04-11
    Communication number: 371-449360 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Suzy McDonald, Assistant Deputy Minister, FPRSP | Federal-Provincial Relations and Social Policy Branch | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2019-03-04
    Posted date: 2019-04-11
    Communication number: 371-449358 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2019-02-13
    Posted date: 2019-03-08
    Communication number: 371-446781 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean-Guy Forgeron, Assistant Secretary, Regulatory Affairs Sector | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-02-05
    Posted date: 2019-03-08
    Communication number: 371-446778 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-02-04
    Posted date: 2019-03-08
    Communication number: 371-446773 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2019-02-01
    Posted date: 2019-03-08
    Communication number: 371-446780 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2019-02-01
    Posted date: 2019-03-08
    Communication number: 371-446776 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rachel Wernick, Senior Assistant Deputy Minister | Employment and Social Development Canada (ESDC)

    Subject Matter of the communication: Education, Employment and Training, Health, Immigration, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2019-01-31
    Posted date: 2019-02-12
    Communication number: 371-444941 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Karina Rolland, Stakeholder Relations Advisor | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2019-01-30
    Posted date: 2019-11-28
    Communication number: 371-460932 (amended from 371-444935) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bill Morneau, Minister of Finance | Finance Canada (FIN)
    • Ben Chin, Chief of Staff | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2019-01-25
    Posted date: 2019-02-12
    Communication number: 371-444933 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-01-24
    Posted date: 2019-02-12
    Communication number: 371-444929 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mathieu Bouchard, Senior Advisor | Prime Minister's Office (PMO)
    • Rick Theis, Policy Advisor | Prime Minister's Office (PMO)
    • Dominic Cormier, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2019-01-23
    Posted date: 2019-02-12
    Communication number: 371-445038 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ben Chin, Chief of Staff | Finance Canada (FIN)
    • Dev Saxena, Senior Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property
    Communication date: 2019-01-21
    Posted date: 2019-02-12
    Communication number: 371-444926 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dominic Cormier, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, International Relations
    Communication date: 2019-01-21
    Posted date: 2019-02-12
    Communication number: 371-444924 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rick Theis, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-01-18
    Posted date: 2019-02-12
    Communication number: 371-444923 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2019-01-18
    Posted date: 2019-02-12
    Communication number: 371-444921 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2019-01-17
    Posted date: 2019-02-12
    Communication number: 371-444919 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2019-01-15
    Posted date: 2019-02-12
    Communication number: 371-444917 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marian Campbell Jarvis, Assistant Secretary to the Cabinet | Privy Council Office (PCO)

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property
    Communication date: 2019-01-14
    Posted date: 2019-02-12
    Communication number: 371-444912 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-12-19
    Posted date: 2019-01-11
    Communication number: 371-443329 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • John O'neill, Minister and Deputy Permanent Representative to the World Trade Organisation | Goverment of Canada Permanent Mission of Canada | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry, International Trade
    Communication date: 2018-12-05
    Posted date: 2019-01-11
    Communication number: 371-443330 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-11-23
    Posted date: 2018-12-12
    Communication number: 371-441511 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rick Theis, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-11-23
    Posted date: 2018-12-12
    Communication number: 371-441509 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Majid Jowhari, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2018-11-08
    Posted date: 2018-12-12
    Communication number: 371-441508 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mona Fortier, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, International Trade
    Communication date: 2018-11-05
    Posted date: 2018-12-12
    Communication number: 371-441506 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Colin Carrie, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2018-11-05
    Posted date: 2018-12-12
    Communication number: 371-441504 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Frank Baylis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2018-10-18
    Posted date: 2018-11-14
    Communication number: 371-438523 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2018-10-17
    Posted date: 2018-11-14
    Communication number: 371-438540 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2018-10-17
    Posted date: 2018-11-14
    Communication number: 371-438529 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marilyn Gladu, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2018-10-15
    Posted date: 2018-11-14
    Communication number: 371-438526 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Karina Rolland, Stakeholder Relations Advisor | House of Commons
    • Benjamin Martin, Member's Assistant | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2018-10-11
    Posted date: 2019-11-28
    Communication number: 371-460930 (amended from 371-438516) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Health Canada (HC)
    • Abby Hoffman, Assistant Deputy Minister - Strategic Policy | Health Canada (HC)
    • Kathryn Nowers, Director of Policy | Health Canada (HC)
    • John Knubley, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Paul Halucha, Sr Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2018-10-05
    Posted date: 2018-11-14
    Communication number: 371-438500 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2018-10-04
    Posted date: 2018-11-14
    Communication number: 371-438556 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2018-10-03
    Posted date: 2018-11-14
    Communication number: 371-438554 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-10-02
    Posted date: 2018-11-14
    Communication number: 371-438546 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Regional Development, Science and Technology
    Communication date: 2018-09-28
    Posted date: 2018-10-12
    Communication number: 371-435090 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)
    • Rick Theis, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2018-09-27
    Posted date: 2018-10-12
    Communication number: 371-435096 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Raj Saini, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Internal Trade, Science and Technology
    Communication date: 2018-09-27
    Posted date: 2018-10-12
    Communication number: 371-435091 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rick Theis, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Government Procurement, Health, Industry, Science and Technology
    Communication date: 2018-09-26
    Posted date: 2018-10-12
    Communication number: 371-435105 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2018-09-26
    Posted date: 2018-10-12
    Communication number: 371-435089 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rick Theis, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Government Procurement, Health, Industry, Science and Technology
    Communication date: 2018-09-25
    Posted date: 2018-10-12
    Communication number: 371-435107 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rick Theis, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Government Procurement, Health, Industry, Science and Technology
    Communication date: 2018-09-21
    Posted date: 2018-10-12
    Communication number: 371-435100 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Karina Rolland-Sardana, Stakeholder Relations Advisor | House of Commons

    Subject Matter of the communication: Health, Industry, Regional Development
    Communication date: 2018-09-18
    Posted date: 2019-11-28
    Communication number: 371-460931 (amended from 371-435094) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Government Procurement, Health, Industry, Science and Technology
    Communication date: 2018-09-18
    Posted date: 2018-10-12
    Communication number: 371-435114 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rick Theis, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Government Procurement, Health, Industry, Science and Technology
    Communication date: 2018-09-13
    Posted date: 2018-10-12
    Communication number: 371-435109 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Government Procurement, Health, Industry, Science and Technology
    Communication date: 2018-09-12
    Posted date: 2018-10-12
    Communication number: 371-435113 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Government Procurement, Health, Industry, Science and Technology
    Communication date: 2018-09-12
    Posted date: 2018-10-12
    Communication number: 371-435110 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2018-09-10
    Posted date: 2018-10-12
    Communication number: 371-435088 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-08-30
    Posted date: 2018-09-10
    Communication number: 371-433279 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rick Theis, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Government Procurement, Health, Industry
    Communication date: 2018-08-24
    Posted date: 2018-09-10
    Communication number: 371-433282 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rick Theis, Policy Advisor | Prime Minister's Office (PMO)
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Employment and Training, Government Procurement, Health, Industry, Infrastructure, Intellectual Property, Science and Technology, Small Business
    Communication date: 2018-08-16
    Posted date: 2018-09-10
    Communication number: 371-433283 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2018-08-14
    Posted date: 2018-09-10
    Communication number: 371-433280 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2018-08-10
    Posted date: 2018-10-03
    Communication number: 371-434384 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean-Guy Forgeron, Assistant Secretary, Regulatory Affairs Sector | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-07-26
    Posted date: 2018-08-03
    Communication number: 371-431833 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Anil Arora, Chief Statistician of Canada | Statistics Canada (StatCan)
    • Jane Badets, Assistant Chief Statistician | Statistics Canada (StatCan)
    • André Loranger, Assistant Chief Statistician | Statistics Canada (StatCan)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2018-07-23
    Posted date: 2018-08-03
    Communication number: 371-431825 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marian Campbell Jarvis, Assistant Secretary to the Cabinet, Social Development Policy | Privy Council Office (PCO)
    • Kate Power, Policy Advisor | Privy Council Office (PCO)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-07-20
    Posted date: 2018-08-03
    Communication number: 371-431829 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-07-19
    Posted date: 2018-08-03
    Communication number: 371-431832 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Maximilien Roy, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-07-18
    Posted date: 2018-08-03
    Communication number: 371-431831 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-07-17
    Posted date: 2018-08-03
    Communication number: 371-431827 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-07-13
    Posted date: 2018-08-03
    Communication number: 371-431835 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mathieu Bouchard, Senior Advisor | Prime Minister's Office (PMO)
    • Rick Theis, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, International Relations, Science and Technology
    Communication date: 2018-07-12
    Posted date: 2018-08-03
    Communication number: 371-431828 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-07-04
    Posted date: 2018-08-03
    Communication number: 371-431826 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rick Theis, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-06-29
    Posted date: 2018-07-13
    Communication number: 371-430896 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Monique Lugli, Senior Advisor | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-06-28
    Posted date: 2018-07-13
    Communication number: 371-430835 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ginette Petitpas Taylor, Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-06-28
    Posted date: 2018-07-13
    Communication number: 371-430833 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2018-06-28
    Posted date: 2018-07-13
    Communication number: 371-430829 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-06-27
    Posted date: 2018-07-13
    Communication number: 371-430855 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rick Theis, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-06-26
    Posted date: 2018-07-13
    Communication number: 371-430895 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-06-22
    Posted date: 2018-07-13
    Communication number: 371-430858 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-06-20
    Posted date: 2018-07-13
    Communication number: 371-430861 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2018-06-19
    Posted date: 2018-07-13
    Communication number: 371-430878 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-06-19
    Posted date: 2018-07-13
    Communication number: 371-430867 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-06-18
    Posted date: 2018-07-13
    Communication number: 371-430870 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rick Theis, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-06-14
    Posted date: 2018-07-13
    Communication number: 371-430884 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-06-14
    Posted date: 2018-07-13
    Communication number: 371-430880 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-06-01
    Posted date: 2018-07-13
    Communication number: 371-430872 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ginette Petitpas Taylor, Minister of Health | Health Canada (HC)
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2018-06-01
    Posted date: 2018-07-13
    Communication number: 371-430847 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-05-31
    Posted date: 2018-06-12
    Communication number: 371-428027 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-05-30
    Posted date: 2018-06-12
    Communication number: 371-428030 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-05-30
    Posted date: 2018-06-12
    Communication number: 371-428028 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-05-28
    Posted date: 2018-06-12
    Communication number: 371-428021 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-05-25
    Posted date: 2018-06-12
    Communication number: 371-428023 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2018-05-22
    Posted date: 2018-06-12
    Communication number: 371-428026 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
    • David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-05-22
    Posted date: 2018-06-12
    Communication number: 371-428025 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rick Theis, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2018-05-17
    Posted date: 2018-06-12
    Communication number: 371-428047 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Maximilien Roy, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-05-17
    Posted date: 2018-06-12
    Communication number: 371-428046 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Maximilien Roy, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health
    Communication date: 2018-05-15
    Posted date: 2018-06-12
    Communication number: 371-428045 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
    • David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-05-15
    Posted date: 2018-06-12
    Communication number: 371-428042 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rick Theis, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2018-05-14
    Posted date: 2018-06-12
    Communication number: 371-428041 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-05-11
    Posted date: 2018-06-12
    Communication number: 371-428034 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-05-08
    Posted date: 2018-06-12
    Communication number: 371-428037 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hon Ginette Petitpas Taylor, Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-05-05
    Posted date: 2018-06-12
    Communication number: 371-428017 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-05-03
    Posted date: 2018-06-12
    Communication number: 371-428036 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
    • David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2018-05-01
    Posted date: 2018-06-12
    Communication number: 371-428032 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Maxime Dea, Policy Advisor | Prime Minister's Office (PMO)
    • Rick Theis, Policy Advisor | Prime Minister's Office (PMO)
    • Mathieu Bouchard, Senior Advisor | Prime Minister's Office (PMO)
    • Elder Marques, Senior Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2018-04-26
    Posted date: 2018-05-11
    Communication number: 371-425728 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gianluca Cairo, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)
    • David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)
    • Hilary Travis, Special Assistant (Policy) | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2018-04-26
    Posted date: 2018-05-11
    Communication number: 371-425725 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Genevieve Hinse, Chief of Staff | Health Canada (HC)
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-04-26
    Posted date: 2018-05-11
    Communication number: 371-425723 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-04-26
    Posted date: 2018-05-11
    Communication number: 371-425721 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-04-17
    Posted date: 2018-05-11
    Communication number: 371-425748 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-04-17
    Posted date: 2018-05-11
    Communication number: 371-425733 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Maxime Dea, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2018-04-06
    Posted date: 2018-05-11
    Communication number: 371-425749 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-04-06
    Posted date: 2018-05-11
    Communication number: 371-425743 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-04-05
    Posted date: 2018-05-11
    Communication number: 371-425745 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Maximilien Roy, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health
    Communication date: 2018-04-04
    Posted date: 2018-05-11
    Communication number: 371-425741 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-04-04
    Posted date: 2018-05-11
    Communication number: 371-425735 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Abby Hoffman, Assistant Deputy Minister - Strategic Policy | Health Canada (HC)
    • Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Simon Kennedy, Deputy Minister | Health Canada (HC)
    • John Knubley, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Gianluca Cairo, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)
    • David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)
    • Genevieve Hinse, Chief of Staff | Health Canada (HC)
    • Kathryn Nowers, Director of Policy | Health Canada (HC)
    • Hilary Travis, Special Assistant (Policy) | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2018-04-03
    Posted date: 2018-05-14
    Communication number: 371-426048 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Special Assistant (Policy) | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-03-30
    Posted date: 2018-04-13
    Communication number: 371-423836 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Maximilien Roy, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Science and Technology, Taxation and Finance
    Communication date: 2018-03-29
    Posted date: 2018-04-13
    Communication number: 371-423820 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Richard Botham, Assistant Deputy Minister | Finance Canada (FIN)

    Subject Matter of the communication: Health, Science and Technology, Taxation and Finance
    Communication date: 2018-03-29
    Posted date: 2018-04-13
    Communication number: 371-423778 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-03-27
    Posted date: 2018-04-13
    Communication number: 371-423795 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-03-20
    Posted date: 2018-04-13
    Communication number: 371-423808 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Maxime Dea, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-03-14
    Posted date: 2018-04-13
    Communication number: 371-423815 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-03-14
    Posted date: 2018-04-13
    Communication number: 371-423799 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-03-13
    Posted date: 2018-04-13
    Communication number: 371-423806 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Maxime Dea, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-03-12
    Posted date: 2018-04-13
    Communication number: 371-423817 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-03-12
    Posted date: 2018-04-13
    Communication number: 371-423803 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Maxime Dea, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-03-08
    Posted date: 2018-04-13
    Communication number: 371-423810 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-03-08
    Posted date: 2018-04-13
    Communication number: 371-423801 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Christopher MacLennan, Assistant Deputy Minister | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, International Relations
    Communication date: 2018-03-07
    Posted date: 2018-04-13
    Communication number: 371-423770 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jonathan Fried, Coordinator, International Economic Relations | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, International Relations
    Communication date: 2018-03-07
    Posted date: 2018-04-13
    Communication number: 371-423767 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean-Guy Forgeron, Assistant Secretary, Regulatory Affairs Secretariat | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-03-02
    Posted date: 2018-04-13
    Communication number: 371-423774 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • John Burnett, Director of Policy | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2018-02-20
    Posted date: 2018-03-13
    Communication number: 371-421450 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Maxime Dea, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2018-02-13
    Posted date: 2018-03-13
    Communication number: 371-421446 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Emmanuella Lambropoulos, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2018-02-07
    Posted date: 2018-03-13
    Communication number: 371-421445 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mona Nemer, Chief of Science Advisor | Innovation, Science and Economic Development Canada (ISED)
    • Luc Gauthier, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2018-02-05
    Posted date: 2018-03-13
    Communication number: 371-421449 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gianluca Cairo, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)
    • David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2018-02-05
    Posted date: 2018-03-13
    Communication number: 371-421447 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hon Navdeep Bains, Minister | Innovation, Science and Economic Development Canada (ISED)
    • Gianluca Cairo, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)
    • Susan Bincoletto, Ambassador of Canada to Switzerland and Liechtenstein | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry, Intellectual Property, International Trade
    Communication date: 2018-01-23
    Posted date: 2018-02-09
    Communication number: 371-419144 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)
    • Hilary Travis, Special Assistant (Policy) | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2017-11-14
    Posted date: 2017-12-13
    Communication number: 371-415681 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Health Canada (HC)
    • Abby Hoffman, Assistant Deputy Minister - Strategic Policy | Health Canada (HC)
    • Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)
    • Kendal Weber, Associate Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2017-11-14
    Posted date: 2017-12-13
    Communication number: 371-415675 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Don Davies, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2017-11-08
    Posted date: 2017-12-13
    Communication number: 371-415679 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Karen Ludwig, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2017-11-02
    Posted date: 2017-12-13
    Communication number: 371-415678 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tracey Ramsey, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2017-11-02
    Posted date: 2017-12-13
    Communication number: 371-415676 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Maxime Dea, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2017-10-30
    Posted date: 2017-11-21
    Communication number: 371-414058 (amended from 371-413065) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Earl Dreeshen, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2017-10-30
    Posted date: 2017-11-15
    Communication number: 371-413069 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David McGovern, Associate Deputy Minister | Office of the Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2017-08-30
    Posted date: 2017-09-11
    Communication number: 371-407527 (amended from 371-407520) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Abby Hoffman, Assistant Deputy Minister - Strategic Policy | Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2017-07-11
    Posted date: 2017-08-15
    Communication number: 371-406506 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David McFarlane, Director of Policy | Minister's Office | Innovation, Science and Economic Development Canada (ISED)
    • Parvinder Sachdeva, Policy Advisor | Minister's Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2017-07-06
    Posted date: 2017-08-15
    Communication number: 371-406504 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Genevieve Hinse, Chief of Staff | Minister of Health Office | Health Canada (HC)
    • Caroline Pitfield, Director of Policy | Minister of Health Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2017-06-29
    Posted date: 2017-07-07
    Communication number: 371-404689 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Megan Buttle, Special Assistant | Innovation, Science and Economic Development Canada (ISED)
    • Javid Dharas, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
    • Parvidner Sachdeva, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2017-04-13
    Posted date: 2017-05-15
    Communication number: 371-400524 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David MacNaughton, Canada's Ambassador to the United States | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2017-04-11
    Posted date: 2017-05-15
    Communication number: 371-400529 (amended from 371-400523) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Francois-Philippe Champagne, Minister of International Trade | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry, Intellectual Property, International Trade
    Communication date: 2017-04-10
    Posted date: 2017-05-15
    Communication number: 371-400526 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, International Trade
    Communication date: 2017-04-05
    Posted date: 2017-05-15
    Communication number: 371-400525 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Daniel Costello, Ambassador of Canada to the European Union | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry, Intellectual Property, International Trade
    Communication date: 2017-04-04
    Posted date: 2017-05-15
    Communication number: 371-400528 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Darshan Kang, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2017-04-03
    Posted date: 2017-05-15
    Communication number: 371-400527 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tyler Meredith, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2017-03-15
    Posted date: 2017-04-15
    Communication number: 371-398406 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David Lametti, Member of Parliament | House of Commons
    • Parvinder Sachdeva, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2017-02-23
    Posted date: 2017-03-15
    Communication number: 371-396082 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Frank Baylis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2017-02-07
    Posted date: 2017-03-15
    Communication number: 371-396092 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2017-02-03
    Posted date: 2017-03-15
    Communication number: 371-396088 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Chief Trade Negotiator (Canada European-Union) | Trade Agreements and Negotiations | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2017-01-30
    Posted date: 2017-02-15
    Communication number: 371-393333 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Megan Buttle, Member's Assistant | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-12-07
    Posted date: 2017-01-16
    Communication number: 371-392179 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David Lametti, Member of Parliament | House of Commons
    • Megan Buttle, Member's Assistant | House of Commons
    • Vincent Garneau, Director of Parliamentary Affairs | Global Affairs Canada (GAC)
    • Steve Verheul, Chief Trade Negotiator (Canada-European Union) | Trade Agreements and Negotiations | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-12-01
    Posted date: 2017-01-16
    Communication number: 371-392178 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Parvinder Sachdeva, Policy Advisor | Minister's Office | Innovation, Science and Economic Development Canada (ISED)
    • Javid Dharas, Policy Advisor | Minister's Office | Innovation, Science and Economic Development Canada (ISED)
    • Marc Gervais, Director of Parliamentary Affairs and Issues Management | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-12-01
    Posted date: 2017-01-16
    Communication number: 371-392176 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kelvin K. Ogilvie, Honourable Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-11-16
    Posted date: 2016-12-15
    Communication number: 371-389245 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Javid Dharas, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
    • David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-11-16
    Posted date: 2016-12-15
    Communication number: 371-389244 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dev Saxena, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
    • Javid Dharas, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-11-04
    Posted date: 2016-12-15
    Communication number: 371-389246 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Javid Dharas, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-11-04
    Posted date: 2016-12-15
    Communication number: 371-389243 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dev Saxena, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
    • David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2016-10-20
    Posted date: 2016-11-15
    Communication number: 371-386814 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Policy Advisor | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-10-07
    Posted date: 2016-11-15
    Communication number: 371-386816 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephanie Delorme, Stakeholder Relations Advisor | Conservative Research Bureau | House of Commons
    • Cam Vidler, Senior Economic Policy Advisor | Conservative Research Bureau | House of Commons
    • Katie Locke, Manager Stakeholder Relations / Sr. Advisor | Conservative Research Bureau | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-08-22
    Posted date: 2019-11-28
    Communication number: 371-460933 (amended from 371-383127) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Abby Hoffman, Assistant Deputy Minister | Strategic Policy Branch | Health Canada (HC)
    • Simon Kennedy, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-07-28
    Posted date: 2016-08-15
    Communication number: 371-381927 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Christopher A. Berzins, Director of Policy | Office of the Minister of Foreign Affairs | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-07-27
    Posted date: 2016-08-15
    Communication number: 371-381929 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Halucha, Associate Assistant Deputy Minister | Strategic Policy Sector | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-07-26
    Posted date: 2016-08-15
    Communication number: 371-381928 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Claude-Éric Gagné, Deputy Director of Operations | Operations | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-06-16
    Posted date: 2016-07-15
    Communication number: 371-381003 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Halucha, Associate Assistant Deputy Minister | Strategic Policy Sector | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-06-14
    Posted date: 2016-07-15
    Communication number: 371-381001 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Majid Jowhari, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-06-06
    Posted date: 2016-07-15
    Communication number: 371-381000 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steven MacKinnon, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-06-02
    Posted date: 2016-07-15
    Communication number: 371-380999 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Carlene Variyan, Director of Parliamentary Affairs | Minister's Office | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-06-02
    Posted date: 2016-07-15
    Communication number: 371-380998 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Celina Caesar-Chavannes, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-06-02
    Posted date: 2016-07-15
    Communication number: 371-380996 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Don Davies, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-06-01
    Posted date: 2016-07-15
    Communication number: 371-380995 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Halucha, Associate Assistant Deputy Minister | Strategic Policy Sector, Office of the Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-05-24
    Posted date: 2016-06-15
    Communication number: 371-378095 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Cyrus Reporter, Senior Advisor to the Prime Minister | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-05-16
    Posted date: 2018-09-10
    Communication number: 371-433285 (amended from 371-378089) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Health Canada (HC)
    • Lawrence Cheung, Senior Policy Advisor | Office of the Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-05-13
    Posted date: 2016-06-15
    Communication number: 371-378093 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Les Linklater, Deputy Secretariat to the Cabinet | Privy Council Office (PCO)
    • Ian Burney, Assistant Secretary to the Cabinet | Economic and Regional Development Policy | Privy Council Office (PCO)

    Subject Matter of the communication: Health, Intellectual Property, International Trade
    Communication date: 2016-05-13
    Posted date: 2016-06-15
    Communication number: 371-378090 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Robert Oliphant, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-05-12
    Posted date: 2016-06-15
    Communication number: 371-378094 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rachael Harder, Member of Parliament | House of Commons

    Subject Matter of the communication: Industry, Intellectual Property, Science and Technology
    Communication date: 2016-05-11
    Posted date: 2016-06-15
    Communication number: 371-378096 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • John Knubley, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Philip Jennings, Assistant Deputy Minister | Industry Sector | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-05-10
    Posted date: 2016-06-15
    Communication number: 371-378087 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Vincent Garneau, Director of Parliamentary Affairs | Office of the Minister of International Trade | Global Affairs Canada (GAC)
    • Christopher Berzins, Director of Policy | Office of the Minister of Foreign Affairs | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-05-06
    Posted date: 2016-06-15
    Communication number: 371-378092 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Geller, Assistant Deputy Minister | Heath Environments and Consumer Safety Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Justice and Law Enforcement, Science and Technology
    Communication date: 2016-05-04
    Posted date: 2016-06-15
    Communication number: 371-378091 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Raj Grewal, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-05-02
    Posted date: 2016-06-15
    Communication number: 371-378088 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dan Costello, Assistant Deputy Minister, Europe | Middle East and Maghreb Innovation | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-04-26
    Posted date: 2016-05-16
    Communication number: 371-375859 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Glover, Associate Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-04-20
    Posted date: 2016-05-16
    Communication number: 371-375861 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Terry Beech, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-04-11
    Posted date: 2016-05-16
    Communication number: 371-375862 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Justin To, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-04-05
    Posted date: 2016-05-16
    Communication number: 371-375860 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sarah Hussaini, Policy Advisor | Office of the Minister of International Trade | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-03-31
    Posted date: 2016-04-15
    Communication number: 371-373799 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Francesco Sorbara, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-03-31
    Posted date: 2016-04-15
    Communication number: 371-373798 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tracey Ramsey, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-03-25
    Posted date: 2016-04-15
    Communication number: 371-373797 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jonathan T. Fried, Ambassador and Permanent Representative of Canada to the WTO, Geneva | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-03-22
    Posted date: 2016-04-15
    Communication number: 371-373796 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marc Serré, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-03-22
    Posted date: 2016-04-15
    Communication number: 371-373795 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Terry Beech, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-03-21
    Posted date: 2016-04-15
    Communication number: 371-373794 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Scott Simms, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-03-21
    Posted date: 2016-04-15
    Communication number: 371-373793 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Anil Arora, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-03-16
    Posted date: 2016-04-15
    Communication number: 371-373792 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Cam Vidler, Senior Economic Policy Advisor | Conservative Research Bureau, Conservative Party of Canada | House of Commons
    • Katie Locke, Manager, Stakeholder Relations / Senior Advisor | Office of the Leader of the Opposition, Conservative Party of Canada | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-03-10
    Posted date: 2016-04-15
    Communication number: 371-373791 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chrystia Freeland, Minister | Global Affairs Canada (GAC)
    • Steve Verheul, Chief Trade Negotiator (Canada-European Union) | Trade Agreements and Negotiations | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-03-03
    Posted date: 2016-04-15
    Communication number: 371-373790 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Elder Marques, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-03-02
    Posted date: 2016-04-15
    Communication number: 371-373789 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marco Mendicino, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-02-25
    Posted date: 2016-03-15
    Communication number: 371-371050 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Colin Fraser, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-02-25
    Posted date: 2016-03-15
    Communication number: 371-371048 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Barbara Glover, Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-02-25
    Posted date: 2016-03-15
    Communication number: 371-371043 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pablo Rodriguez, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-02-23
    Posted date: 2016-03-15
    Communication number: 371-371047 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David Lametti, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-02-18
    Posted date: 2016-03-15
    Communication number: 371-371045 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Colin Bird, Minister-Counselor | Economic and Trade Policy, Embassy of Canada in Washington D.C. | Global Affairs Canada (GAC)
    • Gilles Gauthier, Minister | Economy, Embassy of Canada in Washington D.C. | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-02-17
    Posted date: 2016-03-15
    Communication number: 371-372337 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jane Philpott, Minister | Health Canada (HC)
    • Caroline Pitfield, Director of Policy | Minister's Office | Health Canada (HC)
    • Genevieve Hinse, Chief of Staff | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-02-08
    Posted date: 2016-03-15
    Communication number: 371-371052 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alexandra Bugailskis, Assistant Deputy Minister, Europe, Middle East and Maghreb | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-02-04
    Posted date: 2016-03-15
    Communication number: 371-371058 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Chief Trade Negotiator (Canada-European Union) | Trade Agreements and Negotiations | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-02-04
    Posted date: 2016-03-15
    Communication number: 371-371056 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Francis Drouin, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-02-01
    Posted date: 2016-03-15
    Communication number: 371-371049 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • TJ Harvey, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-01-28
    Posted date: 2016-02-15
    Communication number: 371-368514 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ginette Petitpas Taylor, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-01-27
    Posted date: 2016-02-15
    Communication number: 371-368516 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rodger Cuzner, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-01-27
    Posted date: 2016-02-15
    Communication number: 371-368507 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rob Rosenfeld, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-01-26
    Posted date: 2016-02-15
    Communication number: 371-368504 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Anil Arora, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-01-25
    Posted date: 2016-02-15
    Communication number: 371-368445 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sean Fraser, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-01-21
    Posted date: 2016-02-15
    Communication number: 371-368511 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Robert Asselin, Director of Policy | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-01-21
    Posted date: 2016-02-15
    Communication number: 371-368509 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Greg Fergus, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-01-21
    Posted date: 2016-02-15
    Communication number: 371-368502 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tyler Meredith, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-01-18
    Posted date: 2016-02-15
    Communication number: 371-368517 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • William Blair, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-12-10
    Posted date: 2016-01-15
    Communication number: 371-366336 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kelvin K Ogilvie, Honourable Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-12-09
    Posted date: 2016-01-15
    Communication number: 371-366333 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sven Spengemann, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-12-08
    Posted date: 2016-01-15
    Communication number: 371-366332 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jennifer O'Connell, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-12-08
    Posted date: 2016-01-15
    Communication number: 371-366331 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • John Pecman, Commissioner of Competition | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-12-07
    Posted date: 2016-01-15
    Communication number: 371-366334 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Chief Trade Negotiator | Canada-European Union | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-12-01
    Posted date: 2016-01-15
    Communication number: 371-366335 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Randall Garrison, Member of Parliament | Members of the House of Commons | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-11-30
    Posted date: 2015-12-15
    Communication number: 371-364713 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gavin Liddy, Associate Deputy Minister | Office of the Deputy Minister and Deputy Receiver General for Canada | Public Services and Procurement Canada (PSPC)
    • Barbara Glover, Assistant Deputy Minister | Departmental Oversight Branch | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-11-27
    Posted date: 2015-12-15
    Communication number: 371-364711 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Danielle Lauzon, Telecommunications Project Officer | Networks and End Users, Telecom Services, Fixed Voice Telephony Services | Shared Services Canada (SSC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-11-26
    Posted date: 2015-12-15
    Communication number: 371-364712 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dan Costello, Assistant Deputy Minister, Europe | Middle East and Maghreb Innovation | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-11-24
    Posted date: 2015-12-15
    Communication number: 371-364742 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Johanne Belisle, Commissioner of Patents, Registrar of Trade-marks and CEO | Canadian Intellectual Property Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-11-10
    Posted date: 2015-12-15
    Communication number: 371-364710 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Halucha, Associate Assistant Deputy Minister | Strategic Policy Sector, Office of the Deputy Minister | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-10-26
    Posted date: 2015-11-16
    Communication number: 371-363347 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Susan Gregson, Assistant Deputy Minister | Asia Pacific | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-10-23
    Posted date: 2015-11-16
    Communication number: 371-363346 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Anil Arora, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-10-23
    Posted date: 2015-11-16
    Communication number: 371-363345 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Anil Arora, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-10-13
    Posted date: 2015-11-16
    Communication number: 371-363344 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Anil Arora, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2015-09-18
    Posted date: 2015-10-15
    Communication number: 371-362164 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Glover, Associate Deputy Minister | Deputy Minister's Office | Health Canada (HC)
    • Simon Kennedy, Deputy Minister | Deputy Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2015-09-16
    Posted date: 2015-10-15
    Communication number: 371-362162 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health
    Communication date: 2015-09-11
    Posted date: 2015-10-15
    Communication number: 371-362163 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kelvin K. Ogilvie, Honourable Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-08-27
    Posted date: 2015-09-15
    Communication number: 371-360865 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Halucha, Associate Assistant Deputy Minister | Office of the Deputy Minister, Strategic Policy Sector | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-07-28
    Posted date: 2015-08-15
    Communication number: 371-359502 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jonathan T. Fried, Ambassador and Permanent Representative of Canada | Conference on Disarmament and World Trade Organization, Geneva, Switzerland | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-06-24
    Posted date: 2015-07-15
    Communication number: 371-357605 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David Van Hemmen, Director of Budget Planning | Minister's Office | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-06-23
    Posted date: 2015-07-15
    Communication number: 371-357608 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alexandra MacEachern, Policy Advisor | Minister of Industry | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-06-11
    Posted date: 2015-07-15
    Communication number: 371-357609 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Lise-Ann Jackson, Deputy Chief of Staff/Director, Strategic Planning & Stakeholder Relations | Minister of International Trade | Foreign Affairs, Trade and Development Canada
    • Kirsten Hillman, Associate Assistant Deputy Minister | Trade Agreements and Negotiations | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-06-11
    Posted date: 2015-07-15
    Communication number: 371-357606 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-06-04
    Posted date: 2015-07-15
    Communication number: 371-357604 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-06-03
    Posted date: 2015-07-15
    Communication number: 371-357603 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Anil Arora, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-05-29
    Posted date: 2015-06-15
    Communication number: 371-355820 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Halucha, Associate Assistant Deputy Minister | Strategic Policy Sector | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-05-12
    Posted date: 2015-06-15
    Communication number: 371-355821 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kelvin Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-05-06
    Posted date: 2015-06-15
    Communication number: 371-355822 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hedy Fry, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-04-22
    Posted date: 2015-05-15
    Communication number: 371-353452 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Halucha, Associate Assistant Deputy Minister | Strategic Policy Sector | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-04-17
    Posted date: 2015-05-15
    Communication number: 371-353482 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Trina Morissette, Director of Policy and Stakeholder Relations | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2015-04-17
    Posted date: 2015-05-15
    Communication number: 371-353454 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Halucha, Associate Assistant Deputy Minister | Strategic Policy Sector | Industry Canada
    • John Knubley, Deputy Minister | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-04-15
    Posted date: 2015-05-15
    Communication number: 371-353481 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Chief Trade Negotiator (Canada-European Union) | Trade Agreements and Negotiations | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-04-14
    Posted date: 2015-05-15
    Communication number: 371-353451 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Anil Arora, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-04-14
    Posted date: 2015-05-15
    Communication number: 371-353448 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-04-08
    Posted date: 2015-05-15
    Communication number: 371-353446 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-04-07
    Posted date: 2015-05-15
    Communication number: 371-353445 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kirsten Hillman, Associate Assistant Deputy Minister | Trade Agreements and Negotiations | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-04-02
    Posted date: 2015-05-15
    Communication number: 371-353450 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Phil Harwood, Policy Advisor, Fiscal & Economic Affairs | Policy | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-04-01
    Posted date: 2015-05-15
    Communication number: 371-353449 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ed Holder, Minister of State | Science and Technology | Industry Canada
    • James S. Cowan, Leader of the Opposition | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-03-31
    Posted date: 2015-04-15
    Communication number: 371-350823 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Susan Gregson, Assistant Deputy Minister | Asia Pacific | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-03-30
    Posted date: 2015-04-15
    Communication number: 371-350819 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rona Ambrose, Minister of Health | Minister's Office | Health Canada (HC)
    • Nik Zylstra, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-03-13
    Posted date: 2015-04-15
    Communication number: 371-351029 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kennedy Hong, Manager | Appointments | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-03-09
    Posted date: 2015-04-15
    Communication number: 371-350814 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Deputy Minister's Office | Health Canada (HC)
    • Paul Glover, Associate Deputy Minister | Deputy Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-03-06
    Posted date: 2015-04-15
    Communication number: 371-350818 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Moran, Deputy Chief of Staff | New Democratic Party, Leader of the Opposition | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-03-04
    Posted date: 2015-04-15
    Communication number: 371-350815 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sean Speer, Special Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-02-24
    Posted date: 2015-03-16
    Communication number: 371-348863 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Karl Belanger, Principal Secretary | New Democratic Party, Leader of the Opposition | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-02-18
    Posted date: 2015-03-16
    Communication number: 371-348864 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sean Speer, Special Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-02-18
    Posted date: 2015-03-16
    Communication number: 371-348862 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Candice Baetz, Policy Advisor | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-02-12
    Posted date: 2015-03-16
    Communication number: 371-348860 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sean Speer, Special Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-02-11
    Posted date: 2015-03-16
    Communication number: 371-348861 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-02-11
    Posted date: 2015-03-16
    Communication number: 371-348859 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alexandra MacEachern, Policy Advisor | Minister's Office | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-02-09
    Posted date: 2015-03-16
    Communication number: 371-348858 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Nik Zylstra, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2015-02-02
    Posted date: 2015-03-16
    Communication number: 371-348857 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Peggy Nash, Member of Parliament | House of Commons
    • Dan Harris, Member of Parliament | House of Commons

    Subject Matter of the communication: Financial Institutions, Health, Industry, International Trade
    Communication date: 2015-01-27
    Posted date: 2015-02-16
    Communication number: 371-347126 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Don Davies, Member of Parliament | House of Commons
    • Laurin Liu, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-01-27
    Posted date: 2015-02-16
    Communication number: 371-347125 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Florian Olsen, Policy and Stakeholder Relations Officer | Office of the Leader of the Official Opposition | House of Commons
    • Kerry-Ann Taylor, Communications Officer | Office of the Leader of the Official Opposition | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-01-27
    Posted date: 2015-02-16
    Communication number: 371-347120 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • François Desmarais, Policy Advisor | Office of the Minister of Industry | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-01-23
    Posted date: 2015-02-16
    Communication number: 371-347124 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • John Knubley, Deputy Minister | Office of the Deputy Minister | Industry Canada
    • Kelly Gillis, Associate Deputy Minister | Office of the Deputy Minister | Industry Canada
    • Mitch Davies, Assistant Deputy Minister | Office of the Deputy Minister, Strategic Policy Sector | Industry Canada
    • Philip Jennings, Assistant Deputy Minister | Office of the Deputy Minister, Industry Sector | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-01-19
    Posted date: 2015-02-16
    Communication number: 371-347121 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kirsten Hillman, Associate Assistant Deputy Minister | Trade Agreements and Negotiations | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2015-01-14
    Posted date: 2015-02-16
    Communication number: 371-347123 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kirsty Duncan, Member of Parliament | House of Commons
    • Scott Myres, Special Assistant, Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-12-01
    Posted date: 2015-01-15
    Communication number: 371-343337 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Anil Arora, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Relations
    Communication date: 2014-11-24
    Posted date: 2014-12-15
    Communication number: 371-339612 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • James Maunder, Chief of Staff | Industry Canada

    Subject Matter of the communication: Health, Intellectual Property, International Trade, Science and Technology
    Communication date: 2014-11-04
    Posted date: 2014-12-15
    Communication number: 371-339611 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David Sweet, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-11-04
    Posted date: 2014-12-15
    Communication number: 371-339610 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kelvin K Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-11-04
    Posted date: 2014-12-15
    Communication number: 371-339609 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ben Lobb, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-11-04
    Posted date: 2014-12-15
    Communication number: 371-339608 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David Wells, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-10-30
    Posted date: 2014-11-15
    Communication number: 371-337784 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Randy Hoback, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-10-30
    Posted date: 2014-11-15
    Communication number: 371-337783 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Chief Trade Negotiator (Canada-European Union) | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-10-23
    Posted date: 2014-11-15
    Communication number: 371-337789 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ben Lobb, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-10-23
    Posted date: 2014-11-15
    Communication number: 371-337782 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Susan Gregson, Assistant Deputy Minister, Asia Pacific | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: International Relations
    Communication date: 2014-10-09
    Posted date: 2014-11-15
    Communication number: 371-337781 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Don Davies, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-10-08
    Posted date: 2014-11-15
    Communication number: 371-337780 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chrystia Freeland, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-10-06
    Posted date: 2014-11-15
    Communication number: 371-337779 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Chief Trade Negotiator (Canada-European Union) | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-10-03
    Posted date: 2014-11-15
    Communication number: 371-337778 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ashley Andrades, Special Assistant | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-10-03
    Posted date: 2014-11-15
    Communication number: 371-337777 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David Plunkett, Ambassador of Canada to the European Union | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-10-03
    Posted date: 2014-11-15
    Communication number: 371-337776 (amended from 371-337775) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gordon Brown, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-09-25
    Posted date: 2014-10-15
    Communication number: 371-335405 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • James Munder, Chief of Staff | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2014-09-22
    Posted date: 2014-10-15
    Communication number: 371-335404 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jeremy Hunt, Director, Stakeholder Relations and Outreach | Prime Minister's Office (PMO)
    • Cynthia Tran, Advisor, Stakeholder Relations & Outreach | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2014-09-18
    Posted date: 2014-10-15
    Communication number: 371-335403 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Julie Vaux, Chief of Staff | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-09-16
    Posted date: 2014-10-15
    Communication number: 371-335402 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ken Bednarek, Senior Letigation Advisor | Justice Canada (JC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-09-16
    Posted date: 2014-10-15
    Communication number: 371-335400 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alexandra MacEachern, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-09-15
    Posted date: 2014-10-15
    Communication number: 371-335399 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jess Weiser, Director of Policy | Health Canada (HC)
    • Clarke Olsen, Director of Parliamentary Affairs | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2014-09-03
    Posted date: 2014-10-15
    Communication number: 371-335397 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bradley Lattanzi, Policy Advisor, Science and Technology | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-08-25
    Posted date: 2014-09-15
    Communication number: 371-333270 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kelvin Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2014-08-19
    Posted date: 2014-09-15
    Communication number: 371-333269 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kelvin Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry
    Communication date: 2014-08-19
    Posted date: 2014-09-15
    Communication number: 371-333267 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-07-10
    Posted date: 2014-08-15
    Communication number: 371-331099 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jess Weiser, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-07-10
    Posted date: 2014-08-15
    Communication number: 371-331098 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David Belous, Manager, Stakeholder Relations & Outreach | Prime Minister's Office (PMO)
    • Meredith Lilly, Policy Advisor, Foreign Affairs & Trade | Prime Minister's Office (PMO)
    • Lise-Ann Jackson, Director of Operations and Special Projects | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-07-09
    Posted date: 2014-08-15
    Communication number: 371-331097 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mitch Davies, Assistant Deputy Minister | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-07-07
    Posted date: 2014-08-15
    Communication number: 371-331096 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kelvin K. Ogilvie, Honourable Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-07-03
    Posted date: 2014-08-15
    Communication number: 371-331095 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean Rousseau, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-06-28
    Posted date: 2014-07-15
    Communication number: 371-329654 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mike Lake, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2014-06-24
    Posted date: 2014-07-15
    Communication number: 371-329653 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Julie Vaux, Chief of Staff | Health Canada (HC)
    • Jess Weiser, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2014-06-13
    Posted date: 2014-07-15
    Communication number: 371-329652 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kelvin K. Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry
    Communication date: 2014-06-12
    Posted date: 2014-07-15
    Communication number: 371-329651 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gordon Venner, Assistant Deputy Minister | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, International Relations
    Communication date: 2014-06-04
    Posted date: 2014-07-15
    Communication number: 371-329650 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bradley Lattanzi, Policy Advisor, Science and Technology | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-06-03
    Posted date: 2014-07-15
    Communication number: 371-329649 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alayna Johnson, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-05-23
    Posted date: 2014-06-15
    Communication number: 371-326578 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jonathan Fried, Ambassador and Permanent Representative of Canada to the WTO, Geneva | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-05-20
    Posted date: 2014-06-15
    Communication number: 371-326577 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Chief Trade Negotiator (Canada-European Union) | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-05-09
    Posted date: 2014-06-15
    Communication number: 371-326576 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Diane Jacovella, Assistant Deputy Minister | Foreign Affairs, Trade and Development Canada
    • Paul Samson, A/Assistant Deputy Minister | Foreign Affairs, Trade and Development Canada
    • Matthew Senft, Policy Advisor | Foreign Affairs, Trade and Development Canada
    • Joel Bernard, Policy Advisor for La Francophonie | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-05-08
    Posted date: 2014-06-15
    Communication number: 371-326581 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Lois Brown, Member of Parliament | House of Commons
    • Paul Dewar, Member of Parliament | House of Commons
    • Geoff Regan, Member of Parliament | House of Commons
    • Carolyn Bennett, Member of Parliament | House of Commons
    • Wayne Easter, Member of Parliament | House of Commons
    • Dennis Dawson, Senator | Senate of Canada
    • Terry Mercer, Senator | Senate of Canada
    • JoAnne Buth, Senator | Senate of Canada
    • Matthew Senft, Policy Advisor | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-05-08
    Posted date: 2014-06-15
    Communication number: 371-326573 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Meredith Lilly, Policy Advisor, Foreign Affairs & Trade | Prime Minister's Office (PMO)
    • Cynthia Tran, Advisor, Stakeholder Relations & Outreach | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-05-08
    Posted date: 2014-06-15
    Communication number: 371-326571 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alayna Johnson, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-05-07
    Posted date: 2014-06-15
    Communication number: 371-326570 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Graham Howell, Director of Strategic Planning | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-05-06
    Posted date: 2014-06-15
    Communication number: 371-326569 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alayna Johnson, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-04-29
    Posted date: 2014-05-15
    Communication number: 371-323730 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • James Moore, Minister of Industry | Industry Canada
    • Alayna Johnson, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-04-29
    Posted date: 2014-05-15
    Communication number: 371-323700 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Cynthia Tran, Advisor, Stakeholder Relations & Outreach | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-04-14
    Posted date: 2014-05-15
    Communication number: 371-323699 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Erin O'Toole, Parliamentary Secretary | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-04-07
    Posted date: 2014-05-15
    Communication number: 371-323703 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alayna Johnson, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-04-07
    Posted date: 2014-05-15
    Communication number: 371-323698 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Chief Trade Negotiator (Canada-European Union) | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-04-02
    Posted date: 2014-05-15
    Communication number: 371-323702 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Howard Alper, Chair, Science, Technology and Innovation Counsil Secretriat | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-03-14
    Posted date: 2014-04-15
    Communication number: 371-321272 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-03-10
    Posted date: 2014-04-15
    Communication number: 371-321271 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Abby Hoffman, Assistant Deputy Minister - Strategic Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2014-02-20
    Posted date: 2014-03-15
    Communication number: 371-318693 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jonathan Aitchison, Policy Advisor | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-02-19
    Posted date: 2014-03-15
    Communication number: 371-318691 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Julie Vaux, Chief of Staff | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-02-11
    Posted date: 2014-03-15
    Communication number: 371-318690 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Graham Howell, Director of Strategic Planning | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2014-02-07
    Posted date: 2014-03-15
    Communication number: 371-318689 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ben Lobb, Member of Parliament | House of Commons
    • David Wilks, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2014-01-30
    Posted date: 2014-02-15
    Communication number: 371-315452 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rona Ambrose, Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2014-01-24
    Posted date: 2014-02-15
    Communication number: 371-315451 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bradley Lattanzi, Policy Advisor, Science and Technology | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2014-01-23
    Posted date: 2014-02-15
    Communication number: 371-315450 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Graham Howell, Director of Strategic Planning | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2014-01-21
    Posted date: 2014-02-15
    Communication number: 371-315449 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Erin O'Toole, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-12-11
    Posted date: 2014-01-15
    Communication number: 371-312500 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Julie Vaux, Chief of Staff | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-12-10
    Posted date: 2014-01-15
    Communication number: 371-312498 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • George Da Pont, Deputy Minister | Health Canada (HC)
    • Luke Carter, Executive Advisor | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2013-12-05
    Posted date: 2014-01-15
    Communication number: 371-312497 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hélène Laverdière, Member of Parliament | House of Commons
    • Karl Bélanger, Principal Secretary | House of Commons
    • Rosa Kouri, Parliamentary Affairs | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-12-04
    Posted date: 2014-01-15
    Communication number: 371-312496 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Idee Inyangudor, Director of Policy and Stakeholder Relations | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-12-02
    Posted date: 2014-01-15
    Communication number: 371-312495 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rona Ambrose, Minister of Health | Health Canada (HC)
    • Graham Howell, Director of Strategic Planning | Health Canada (HC)
    • Chanel Savoie, Executive Assistant to the Minister | Health Canada (HC)
    • Scott Myers, Special Assistant - Policy, Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-12-02
    Posted date: 2014-01-15
    Communication number: 371-312493 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alayna Johnson, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-11-14
    Posted date: 2013-12-15
    Communication number: 371-309557 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Chief Trade Negotiator (Canada-European Union) | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-11-01
    Posted date: 2013-12-15
    Communication number: 371-309556 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister of International Trade | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-11-01
    Posted date: 2013-12-15
    Communication number: 371-309555 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Dewar, Member of Parliament | House of Commons
    • Hélène Laverdière, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-10-31
    Posted date: 2013-11-15
    Communication number: 371-303621 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Graham Howell, Director of Strategic Planning | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2013-10-31
    Posted date: 2013-11-15
    Communication number: 371-303620 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn McDade, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2013-10-31
    Posted date: 2013-11-15
    Communication number: 371-303619 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn McDade, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2013-10-30
    Posted date: 2013-11-15
    Communication number: 371-303617 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn McDade, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2013-10-29
    Posted date: 2013-11-15
    Communication number: 371-303614 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn McDade, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2013-10-28
    Posted date: 2013-11-15
    Communication number: 371-303615 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Cynthia Tran, Advisor, Stakeholder Relations & Outreach | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-10-24
    Posted date: 2013-11-15
    Communication number: 371-303612 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kelvin K. Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2013-10-16
    Posted date: 2013-11-15
    Communication number: 371-303610 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Julie Vaux, Chief of Staff | Health Canada (HC)
    • Graham Howell, Director of Strategic Planning | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-10-10
    Posted date: 2013-11-15
    Communication number: 371-303609 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jonathan Aitchison, Policy Advisor | Foreign Affairs, Trade and Development Canada
    • Matthew Senft, Policy Advisor | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-10-04
    Posted date: 2013-11-15
    Communication number: 371-303594 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn McDade, Asistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2013-10-03
    Posted date: 2013-11-15
    Communication number: 371-303593 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Adam Taylor, Director of Communications and Forward Planning | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-10-01
    Posted date: 2013-11-15
    Communication number: 371-303591 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gordon Venner, Assitant Deputy Minister | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: Health, Industry
    Communication date: 2013-09-23
    Posted date: 2013-10-15
    Communication number: 371-296269 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marc Garneau, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-09-19
    Posted date: 2013-10-15
    Communication number: 371-296260 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rona Ambrose, Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2013-09-13
    Posted date: 2013-10-15
    Communication number: 371-296257 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kelvin K. Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2013-09-13
    Posted date: 2013-10-15
    Communication number: 371-296255 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • James Nicholson, Director of Policy | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2013-09-03
    Posted date: 2013-10-15
    Communication number: 371-296252 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rodger Cuzner, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2013-08-28
    Posted date: 2013-09-15
    Communication number: 371-290489 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Chief Trade Negotiator (Canada-European Union) | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-07-18
    Posted date: 2013-08-15
    Communication number: 371-286589 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jonathan Aitchison, Senior Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-07-10
    Posted date: 2013-08-15
    Communication number: 371-286590 (amended from 371-286569) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Daniel King, Senior Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-07-10
    Posted date: 2013-08-15
    Communication number: 371-286570 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Lise-Ann Jackson, Director Of Policy and Stakeholder Relations | Foreign Affairs and International Trade Canada (DFAITC)
    • Marisa Monnin, Policy Advisor | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-07-09
    Posted date: 2013-08-15
    Communication number: 371-286552 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister of International Trade | Foreign Affairs and International Trade Canada (DFAITC)
    • Kirsten Hillman, Associate Assistant Deputy Minister | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-07-09
    Posted date: 2013-08-15
    Communication number: 371-286550 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Libby Davies, Member of Parliament | House of Commons
    • Guy Caron, Member of Parliament | House of Commons
    • Carol Hughes, Member of Parliament | House of Commons
    • Karl Bélanger, Principal Secretary | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-06-11
    Posted date: 2013-07-15
    Communication number: 371-280405 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Judith G. Seidman, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2013-06-04
    Posted date: 2013-07-15
    Communication number: 371-280404 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kelvin K. Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2013-05-30
    Posted date: 2013-06-15
    Communication number: 371-277200 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jasmine Brown, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-05-14
    Posted date: 2013-06-15
    Communication number: 371-277199 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rosa Kouri, Parliamentary Affairs | House of Commons
    • Cédric Williams, Parliamentary Affairs | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-05-14
    Posted date: 2013-06-15
    Communication number: 371-277197 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Dewar, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-05-10
    Posted date: 2013-06-15
    Communication number: 371-277195 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tim Norris, Director of Policy | Natural Resources Canada (NRCan)

    Subject Matter of the communication: Industry, Intellectual Property
    Communication date: 2013-05-09
    Posted date: 2013-06-15
    Communication number: 371-277193 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gordon Venner, Assistant Deputy Minister | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: International Relations
    Communication date: 2013-05-08
    Posted date: 2013-06-15
    Communication number: 371-277191 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rob Clarke, Member of Parliament | House of Commons
    • Gord Brown, Member of Parliament | House of Commons
    • Wladyslaw Lizon, Member of Parliament | House of Commons
    • Hedy Fry, Member of Parliament | House of Commons
    • Peter Stoffer, Member of Parliament | House of Commons
    • Karl Bélanger, Principal Secretary | House of Commons
    • Colin Carrie, Member of Parliament | House of Commons
    • Joy Smith, Member of Parliament | House of Commons
    • Carolyn Bennett, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2013-05-07
    Posted date: 2013-06-15
    Communication number: 371-277189 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gordon Bown, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-05-02
    Posted date: 2013-06-15
    Communication number: 371-277180 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jonathan Aitchison, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-04-26
    Posted date: 2013-05-15
    Communication number: 371-273005 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kelvin K. Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry
    Communication date: 2013-04-24
    Posted date: 2013-05-15
    Communication number: 371-273002 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Peter Braid, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2013-04-19
    Posted date: 2013-05-15
    Communication number: 371-272999 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Douglas Smith, Chief of Staff | Human Resources and Skills Development Canada (HRSDC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-04-17
    Posted date: 2013-05-15
    Communication number: 371-272997 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health
    Communication date: 2013-04-17
    Posted date: 2013-05-15
    Communication number: 371-272995 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bruce Stanton, Assistant Deputy Chair of Committees of the Whole | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2013-04-16
    Posted date: 2013-05-15
    Communication number: 371-272994 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Outhouse, Deputy Chief of Staff and Director, Communications | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2013-04-16
    Posted date: 2013-05-15
    Communication number: 371-272991 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dr. Rainer Engelhardt, Assistant Deputy Minister | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2013-03-28
    Posted date: 2013-04-15
    Communication number: 371-268097 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kennedy Stewart, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2013-03-28
    Posted date: 2013-04-15
    Communication number: 371-268096 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Brad Lattanzi, Special Assistant | Industry Canada

    Subject Matter of the communication: Health, Industry, International Trade
    Communication date: 2013-03-27
    Posted date: 2013-04-15
    Communication number: 371-268094 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Don Davies, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-03-26
    Posted date: 2013-04-15
    Communication number: 371-268073 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Patrick Brown, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2013-03-25
    Posted date: 2013-04-15
    Communication number: 371-268092 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-03-18
    Posted date: 2013-04-15
    Communication number: 371-268071 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-03-01
    Posted date: 2013-04-15
    Communication number: 371-268068 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2013-02-20
    Posted date: 2013-03-15
    Communication number: 371-262929 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister of International Trade | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2013-01-31
    Posted date: 2013-02-15
    Communication number: 371-258978 (amended from 371-258849) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Glover, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, International Trade
    Communication date: 2013-01-29
    Posted date: 2013-02-15
    Communication number: 371-258976 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Glover, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2012-12-14
    Posted date: 2013-01-15
    Communication number: 371-253530 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bill Hawkins, Chief of Staff | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-12-14
    Posted date: 2013-01-15
    Communication number: 371-253529 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • John Knubley, Deputy Minister | Industry Canada
    • Philip Jennings, A/Assistant Deputy Minister | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-11-02
    Posted date: 2012-12-15
    Communication number: 371-250353 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kelvin Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-10-16
    Posted date: 2012-11-15
    Communication number: 371-244836 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Lois Brown, Parliamentary Secretary | Canadian International Development Agency (CIDA)
    • Idee Inyangudor, Director of Policy | Canadian International Development Agency (CIDA)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-10-16
    Posted date: 2012-11-15
    Communication number: 371-244832 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Glover, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2012-10-16
    Posted date: 2012-11-15
    Communication number: 371-244830 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Lois Brown, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-10-16
    Posted date: 2012-11-15
    Communication number: 371-244822 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bruce Christie, Minister of Deputy Permanent Representative to the WTO | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-10-11
    Posted date: 2012-11-15
    Communication number: 371-244825 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Glover, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-10-04
    Posted date: 2012-11-15
    Communication number: 371-244818 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mauril Belanger, Member of Parliament | House of Commons
    • John McKay, Member of Parliament | House of Commons
    • Judy Foote, Member of Parliament | House of Commons
    • Peter Braid, Member of Parliament | House of Commons
    • Leon Benoit, Member of Parliament | House of Commons
    • Helene Laverdiere, Member of Parliament | House of Commons
    • Craig Scott, Member of Parliament | House of Commons
    • Bruce Hyer, Member of Parliament | House of Commons
    • Gord Brown, Member of Parliament | House of Commons
    • Francine Raynault, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-10-03
    Posted date: 2012-11-15
    Communication number: 371-244812 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Libby Davies, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-10-01
    Posted date: 2012-11-15
    Communication number: 371-244810 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jason Kenney, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-09-28
    Posted date: 2012-10-15
    Communication number: 371-240763 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Don Davies, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-09-27
    Posted date: 2012-10-15
    Communication number: 371-240762 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Wayne Easter, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-09-26
    Posted date: 2012-10-15
    Communication number: 371-240760 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Shuvaloy Majumdar, Senior Policy Advisor | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-09-21
    Posted date: 2012-10-15
    Communication number: 371-240758 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Thomas Mulcair, Leader of the Opposition | House of Commons
    • Gauri Sreenivasan, Parliamentary Affairs | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-09-20
    Posted date: 2012-10-15
    Communication number: 371-240756 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Christian Paradis, Minister of Industry | Industry Canada
    • Sean O'Leary, Policy Advisor | Industry Canada
    • Margaux Stastny, Communication Director | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-08-27
    Posted date: 2012-09-15
    Communication number: 371-236252 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • John Baird, Minister of Foreign Affairs | Foreign Affairs and International Trade Canada (DFAITC)
    • Steven Farber, Senior Policy Advisor | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-08-20
    Posted date: 2012-09-15
    Communication number: 371-236251 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Glover, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-08-14
    Posted date: 2012-09-15
    Communication number: 371-236234 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • John Anderson, Parliamentary Affairs | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-08-13
    Posted date: 2012-09-15
    Communication number: 371-236231 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Douglas Smith, Chief of Staff | Human Resources and Skills Development Canada (HRSDC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-07-25
    Posted date: 2012-08-15
    Communication number: 371-232315 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Howard Alper, Chair | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-07-24
    Posted date: 2012-08-15
    Communication number: 371-232314 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Giguère, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-07-18
    Posted date: 2012-08-15
    Communication number: 371-232313 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sandra Buckler, Chief of Staff | Health Canada (HC)
    • Leah Canning, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-07-17
    Posted date: 2012-08-15
    Communication number: 371-232312 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)
    • Jane E. Aubin, CSO/VP, Research and Knowledge Translation | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2012-07-13
    Posted date: 2012-08-15
    Communication number: 371-232311 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gauri Screenivasan, Parliamentary Affairs | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-07-11
    Posted date: 2012-10-10
    Communication number: 371-239990 (amended from 371-232309) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dr. Rainer Engelhardt, Assistant Deputy Minister | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2012-06-28
    Posted date: 2012-07-15
    Communication number: 371-229847 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Andrea van Vugt, Policy Advisor, Foreign Affairs, Trade and Intn'l Development | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-06-20
    Posted date: 2012-07-15
    Communication number: 371-229844 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Chief Trade Negotiator (Canada-European Union) | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-06-20
    Posted date: 2012-07-15
    Communication number: 371-229842 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kellie Leitch, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2012-06-15
    Posted date: 2012-07-15
    Communication number: 371-229837 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sean O'Leary, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-06-07
    Posted date: 2012-07-15
    Communication number: 371-229834 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kelvin K. Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-06-06
    Posted date: 2012-07-15
    Communication number: 371-229832 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Peter MacKay, Member of Parliament | House of Commons
    • Lisa Raitt, Member of Parliament | House of Commons
    • Noël Kinsella, Honourable Senator | Senate of Canada
    • Janice Charette, Associate Secretary to the Cabinet & Deputy Minister (IGA) | Privy Council Office (PCO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-06-06
    Posted date: 2012-07-15
    Communication number: 371-229814 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2012-05-25
    Posted date: 2012-06-15
    Communication number: 371-226739 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Robert Carberry, Assistant Secretary, Regulatory Cooperation Council Scretariat | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2012-05-24
    Posted date: 2012-06-15
    Communication number: 371-226738 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ed Holder, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-05-17
    Posted date: 2012-06-15
    Communication number: 371-226737 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rob Merrifield, Member of Parliament | House of Commons

    Subject Matter of the communication: Industry, Intellectual Property, International Relations, International Trade
    Communication date: 2012-05-15
    Posted date: 2012-06-15
    Communication number: 371-226736 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Glover, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2012-05-10
    Posted date: 2012-06-15
    Communication number: 371-226735 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bernard Trottier, Member of Parliament | House of Commons
    • Lois Brown, Member of Parliament | House of Commons
    • John Anderson, Director of Parliamentary Affairs | Office of the Leader of the Official Opposition | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-04-27
    Posted date: 2012-05-15
    Communication number: 371-222807 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2012-03-30
    Posted date: 2012-04-16
    Communication number: 371-217307 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kirsty Duncan, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2012-03-28
    Posted date: 2012-04-16
    Communication number: 371-217288 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Glover, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-03-28
    Posted date: 2012-04-16
    Communication number: 371-217287 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2012-03-26
    Posted date: 2012-04-16
    Communication number: 371-217278 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Glenda Yeates, Deputy Minister | Health Canada (HC)
    • Paul Glover, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-03-15
    Posted date: 2012-04-16
    Communication number: 371-217274 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Chief Trade Negotiator (Canada-European Union) | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-03-09
    Posted date: 2012-04-16
    Communication number: 371-217269 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mark Adler, Member of Parliament | House of Commons
    • Dean Allison, Member of Parliament | House of Commons
    • Gordon Brown, Member of Parliament | House of Commons
    • Patrick Brown, Member of Parliament | House of Commons
    • Rick Dykstra, Member of Parliament | House of Commons
    • Parm Gill, Member of Parliament | House of Commons
    • Bal Gosal, Member of Parliament | House of Commons
    • Larry Miller, Member of Parliament | House of Commons
    • Terence Young, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-03-08
    Posted date: 2012-04-16
    Communication number: 371-217259 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Leona Aglukkaq, Minister | Health Canada (HC)
    • Paul Glover, Assistant Deputy Minister | Health Canada (HC)
    • Amanda Gordon, Executive Assistant to the Minister of Health | Health Canada (HC)
    • Abby Hoffman, Assistant Deputy Minister - Strategic Policy | Health Canada (HC)
    • Scott Tessier, Chief of Staff | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-03-01
    Posted date: 2012-04-16
    Communication number: 371-217252 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • André Bachand, Senior Advisor | Prime Minister's Office (PMO)
    • Sean Speer, Senior Economic Policy Advisor | Prime Minister's Office (PMO)
    • Andrea van Vugt, Policy Advisor, Foreign Affairs, Trade and Int'l Development | Prime Minister's Office (PMO)
    • Phil Harwood, Policy Advisor | Prime Minister's Office (PMO)
    • Stefan Stefanov, Intern | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-02-28
    Posted date: 2012-03-16
    Communication number: 371-211854 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Douglas Smith, Chief of Staff | Human Resources and Skills Development Canada (HRSDC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-02-15
    Posted date: 2012-03-16
    Communication number: 371-211853 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • André Bachand, Senior Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-02-10
    Posted date: 2012-03-16
    Communication number: 371-211852 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Timothy Sargent, Assistant Secretary to the Cabinet | Privy Council Office (PCO)
    • Marie-France Paquet, Director of Operations | Privy Council Office (PCO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-02-09
    Posted date: 2012-03-16
    Communication number: 371-211851 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Douglas Smith, Chief of Staff | Human Resources and Skills Development Canada (HRSDC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-02-08
    Posted date: 2012-03-16
    Communication number: 371-211849 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Glover, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2012-02-01
    Posted date: 2012-03-16
    Communication number: 371-211856 (amended from 371-211846) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Patrick McIntyre, Director of Policy | Industry Canada
    • Benoit Violette, Senior Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-02-01
    Posted date: 2012-03-16
    Communication number: 371-211844 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sean O'Leary, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-01-26
    Posted date: 2012-02-16
    Communication number: 371-207136 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Louise Girouard, Director of Policy and Stakeholder Relations | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-01-18
    Posted date: 2012-02-16
    Communication number: 371-207134 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steven Farber, Senior Policy Advisor | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-01-10
    Posted date: 2012-02-16
    Communication number: 371-207132 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Scott Tessier, Chief of Staff | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-01-06
    Posted date: 2012-02-16
    Communication number: 371-207129 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steven Farber, Senior Policy Advisor | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-12-07
    Posted date: 2012-01-16
    Communication number: 371-202507 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Meredith Lilly, Director of Policy | Human Resources and Skills Development Canada (HRSDC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-11-28
    Posted date: 2011-12-16
    Communication number: 371-199755 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Daniel Kosick, Policy Advisor | Human Resources and Skills Development Canada (HRSDC)
    • Ryan Greer, Senior Policy Advisor | Human Resources and Skills Development Canada (HRSDC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-11-24
    Posted date: 2011-12-16
    Communication number: 371-199752 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • John Connell, Associate Assistant Deputy Minister | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-11-24
    Posted date: 2011-12-16
    Communication number: 371-199749 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Geoffrey Leblovic, Special Assistant, Policy | Privy Council Office (PCO)
    • Natalie Fletcher, Senior Policy Advisor | Privy Council Office (PCO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-11-23
    Posted date: 2011-12-16
    Communication number: 371-199741 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Leon Benoit, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-11-22
    Posted date: 2011-12-16
    Communication number: 371-199739 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dave Van Kesteren, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-11-21
    Posted date: 2011-12-16
    Communication number: 371-199726 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gerald Keddy, Parliamentary Secretary to the Minister of International Trade | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-11-17
    Posted date: 2011-12-16
    Communication number: 371-199730 (amended from 371-199720) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gary Goodyear, Minister of State, Science and Technology | Industry Canada
    • Benoit Violette, Senior Policy Advisor | Industry Canada
    • Patrick McIntyre, Director of Policy | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-11-15
    Posted date: 2011-12-16
    Communication number: 371-199717 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bernard Trottier, Member of Parliament | House of Commons
    • Mike Wallace, Member of Parliament | House of Commons
    • Pierre Lemieux, Member of Parliament | House of Commons
    • Art Eggleton, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-11-10
    Posted date: 2011-12-16
    Communication number: 371-199705 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hélène Laverdière, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-11-08
    Posted date: 2011-12-16
    Communication number: 371-199702 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bernard Trottier, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-31
    Posted date: 2011-11-16
    Communication number: 371-193214 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Aron Seal, Director of Policy | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-31
    Posted date: 2011-11-16
    Communication number: 371-193213 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Michel Rivard, Honourable Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 371-193211 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Christian Paradis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 371-193208 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Denis Lebel, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 371-193207 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Maxime Bernier, Minister of State (Small Business and Tourism) | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 371-193206 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jacques Gourde, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 371-193205 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steven Blaney, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 371-193204 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jacques Demers, Honourable Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 371-193184 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pierre-Hugues Boisvenu, Honourable Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 371-193182 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pierre Claude Nolin, Honourable Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 371-193180 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Larry Smith, Honourable Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 371-193178 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Judith G. Seidman, Honourable Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 371-193177 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Suzanne Fortin-Duplessis, Honourable Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 371-193176 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Claude Carrignan, Honourable Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 371-193175 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Devinder Shory, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-24
    Posted date: 2011-11-16
    Communication number: 371-193174 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Philip Jennings, Associate Assistant Deputy Minister | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-24
    Posted date: 2011-11-16
    Communication number: 371-193173 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gary Schellenberger, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-24
    Posted date: 2011-11-16
    Communication number: 371-193172 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kellie Leitch, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-20
    Posted date: 2011-11-16
    Communication number: 371-193170 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Douglas Smith, Chief of Staff | Human Resources and Skills Development Canada (HRSDC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-19
    Posted date: 2011-11-16
    Communication number: 371-193168 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Philip Jennings, Associate Assistant Deputy Minister | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-19
    Posted date: 2011-11-16
    Communication number: 371-193167 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Lisa Raitt, Minister of Labour | Human Resources and Skills Development Canada (HRSDC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-19
    Posted date: 2011-11-16
    Communication number: 371-193166 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Chief Trade Negotiator (Canada-European Union) | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-18
    Posted date: 2011-11-16
    Communication number: 371-193165 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sean O'Leary, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-18
    Posted date: 2011-11-16
    Communication number: 371-193164 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Philip Jennings, Associate Assistant Deputy Minister | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-18
    Posted date: 2011-11-16
    Communication number: 371-193149 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Christian Paradis, Minister | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-18
    Posted date: 2011-11-16
    Communication number: 371-193148 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Glover, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-18
    Posted date: 2011-11-16
    Communication number: 371-193147 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Laurie Hawn, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-18
    Posted date: 2011-11-16
    Communication number: 371-193146 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rod Bruinooge, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-18
    Posted date: 2011-11-16
    Communication number: 371-193084 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Louis Lévesque, Deputy Minister of International Trade | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-18
    Posted date: 2011-11-16
    Communication number: 371-193080 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • James Rajotte, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-17
    Posted date: 2011-11-16
    Communication number: 371-193078 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David Sweet, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-17
    Posted date: 2011-11-16
    Communication number: 371-193074 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Corneliu Chisu, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-06
    Posted date: 2011-11-16
    Communication number: 371-193073 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rob Merrifield, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-06
    Posted date: 2011-11-16
    Communication number: 371-193072 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rick Dykstra, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-05
    Posted date: 2011-11-16
    Communication number: 371-193069 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Douglas Smith, Chief of Staff | Human Resources and Skills Development Canada (HRSDC)

    Subject Matter of the communication: Industry, Intellectual Property, International Trade
    Communication date: 2011-10-04
    Posted date: 2011-11-16
    Communication number: 371-193068 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mike Wallace, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-04
    Posted date: 2011-11-16
    Communication number: 371-193067 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Colin Carrie, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-04
    Posted date: 2011-11-16
    Communication number: 371-193066 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Glover, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2011-09-29
    Posted date: 2011-10-16
    Communication number: 371-188873 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Glover, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2011-09-26
    Posted date: 2011-10-16
    Communication number: 371-188871 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rodger Cuzner, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-09-21
    Posted date: 2011-10-16
    Communication number: 371-188869 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sophia Arvanitis, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Taxation and Finance
    Communication date: 2011-09-21
    Posted date: 2011-10-16
    Communication number: 371-188868 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kevin M. McCarthy, Chief of Staff | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Taxation and Finance
    Communication date: 2011-09-21
    Posted date: 2011-10-16
    Communication number: 371-188866 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gerald Keddy, Parliamentary Secretary to the Minister of International Trade | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-09-20
    Posted date: 2011-10-16
    Communication number: 371-188970 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rob Merrifield, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-09-20
    Posted date: 2011-10-16
    Communication number: 371-188968 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Chief Trade Negotiator (Canada-European Union) | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-09-20
    Posted date: 2011-10-16
    Communication number: 371-188864 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Edward Fast, Minister of International Trade and Minister for the Asia-Pacific Gateway | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-09-13
    Posted date: 2011-10-16
    Communication number: 371-188841 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gordon Brown, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-09-08
    Posted date: 2011-10-16
    Communication number: 371-188839 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Brad Butt, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-09-07
    Posted date: 2011-10-16
    Communication number: 371-188836 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Patrick Brown, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-09-07
    Posted date: 2011-10-16
    Communication number: 371-188834 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Patrick McIntyre, Director of Policy | Industry Canada

    Subject Matter of the communication: Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2011-08-29
    Posted date: 2011-09-16
    Communication number: 371-185389 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Douglas Smith, Chief of Staff | Human Resources and Skills Development Canada (HRSDC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-08-25
    Posted date: 2011-09-16
    Communication number: 371-185388 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sean O'Leary, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-08-19
    Posted date: 2011-09-16
    Communication number: 371-185387 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dan Baxter, Special Assistant - Projects and Processes | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Intellectual Property, International Trade
    Communication date: 2011-08-17
    Posted date: 2011-09-16
    Communication number: 371-185386 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Louise Girouard, Director of Policy and Stakeholer Relations | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Intellectual Property, International Trade
    Communication date: 2011-08-17
    Posted date: 2011-09-16
    Communication number: 371-185385 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Andrea McGuigan, Policy Advisor, Foreign Affairs, Environment & Energy Security | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Intellectual Property, International Trade
    Communication date: 2011-08-16
    Posted date: 2011-09-16
    Communication number: 371-185384 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Glover, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2011-07-25
    Posted date: 2011-08-16
    Communication number: 371-177546 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Glover, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2011-07-12
    Posted date: 2011-08-16
    Communication number: 371-177525 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gary Doer, Ambassador | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Industry, Intellectual Property, International Relations, International Trade
    Communication date: 2011-06-27
    Posted date: 2011-07-16
    Communication number: 371-175334 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Howard Alper, Chair, Science, Technology and Innovation Council Secretariat | Industry Canada

    Subject Matter of the communication: Industry, Intellectual Property, Science and Technology
    Communication date: 2011-06-23
    Posted date: 2011-07-16
    Communication number: 371-175045 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sean O'Leary, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2011-06-20
    Posted date: 2011-12-07
    Communication number: 371-175328 (amended from 371-175327) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kelvin K. Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2011-06-15
    Posted date: 2011-07-16
    Communication number: 371-175044 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sean O'Leary, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-06-14
    Posted date: 2011-07-16
    Communication number: 371-175326 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2011-06-13
    Posted date: 2011-07-16
    Communication number: 371-175043 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mike Wallace, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2011-06-07
    Posted date: 2011-07-16
    Communication number: 371-175042 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bernard Trottier, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2011-06-07
    Posted date: 2011-07-16
    Communication number: 371-175041 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Lois Brown, Parliamentary Secretary | Canadian International Development Agency (CIDA)

    Subject Matter of the communication: Intellectual Property
    Communication date: 2011-05-25
    Posted date: 2011-06-16
    Communication number: 371-173399 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2011-04-27
    Posted date: 2011-05-16
    Communication number: 371-171896 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Glover, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2011-03-30
    Posted date: 2011-04-16
    Communication number: 371-170615 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rick Theis, Advisor | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-03-03
    Posted date: 2011-12-07
    Communication number: 371-170614 (amended from 371-170613) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mike Allen, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-03-03
    Posted date: 2011-04-16
    Communication number: 371-170612 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mike Wallace, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-03-03
    Posted date: 2011-04-16
    Communication number: 371-170611 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Graham Howell, Senior Special Assistant | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 371-170610 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Leah Canning, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 371-170609 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marlene Jennings, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-03-01
    Posted date: 2011-04-16
    Communication number: 371-170608 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephane Dion, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-03-01
    Posted date: 2011-04-16
    Communication number: 371-170606 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bernard Patry, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-03-01
    Posted date: 2011-04-16
    Communication number: 371-170605 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Glen Pearson, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-03-01
    Posted date: 2011-04-16
    Communication number: 371-170602 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rick Norlock, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-03-01
    Posted date: 2011-04-16
    Communication number: 371-170600 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marlene Jennings, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2011-02-17
    Posted date: 2011-03-16
    Communication number: 371-168029 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • John Gero, Ambassador & Permanent Representative | World Trade Organization (WTO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-02-16
    Posted date: 2011-03-16
    Communication number: 371-168035 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Carolyn Bennett, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-02-11
    Posted date: 2011-03-16
    Communication number: 371-168038 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2011-02-04
    Posted date: 2011-03-16
    Communication number: 371-168139 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Geoffrey Leblovic, Special Assistant | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-02-02
    Posted date: 2011-03-16
    Communication number: 371-168059 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Laanemets, Special Assistant | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-02-02
    Posted date: 2011-03-16
    Communication number: 371-168056 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Adam Church, Senior Policy Advisor | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-02-02
    Posted date: 2011-03-16
    Communication number: 371-168041 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dave Forestell, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-01-27
    Posted date: 2011-02-16
    Communication number: 371-165335 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Richard Dicerni, Deputy Minister | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-01-13
    Posted date: 2011-02-16
    Communication number: 371-165334 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Claude Carrignan, Honourable Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-01-13
    Posted date: 2011-02-16
    Communication number: 371-165333 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tony Clement, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-01-13
    Posted date: 2011-02-16
    Communication number: 371-165332 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2010-12-08
    Posted date: 2011-01-16
    Communication number: 371-163614 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kirsty Duncan, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2010-12-01
    Posted date: 2011-01-16
    Communication number: 371-163612 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Lois Brown, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2010-12-01
    Posted date: 2011-01-16
    Communication number: 371-163608 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ruby Dhalla, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2010-12-01
    Posted date: 2011-01-16
    Communication number: 371-163606 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Keith Martin, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2010-12-01
    Posted date: 2011-01-16
    Communication number: 371-163605 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Chief Trade Negotiator (Canada-European Union) | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2010-11-29
    Posted date: 2010-12-16
    Communication number: 371-161946 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Andrew Saxton, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Industry
    Communication date: 2010-11-29
    Posted date: 2010-12-16
    Communication number: 371-161945 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Lois Brown, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Health
    Communication date: 2010-11-29
    Posted date: 2010-12-16
    Communication number: 371-161944 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gord Brown, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Industry
    Communication date: 2010-11-23
    Posted date: 2010-12-16
    Communication number: 371-161942 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2010-11-04
    Posted date: 2010-12-16
    Communication number: 371-161937 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Michael Winterburn, Speechwriter | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2010-11-02
    Posted date: 2010-12-16
    Communication number: 371-161940 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Claude Carrigan, Honourable Senator | Senate of Canada

    Subject Matter of the communication: Industry, Intellectual Property, International Trade, Justice and Law Enforcement
    Communication date: 2010-10-27
    Posted date: 2010-11-16
    Communication number: 371-159381 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David Sweet, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Health, Intellectual Property, Science and Technology
    Communication date: 2010-10-18
    Posted date: 2010-11-16
    Communication number: 371-159378 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Judith Seidman, Honourable Senators | Senate of Canada

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-16
    Communication number: 371-159418 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Michel Rivard, Honourable Senators | Senate of Canada

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-16
    Communication number: 371-159416 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Suzanne Fortin-Duplessis, Honourable Senators | Senate of Canada

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-16
    Communication number: 371-159413 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jacques Demers, Honourable Senators | Senate of Canada

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-16
    Communication number: 371-159410 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Andree Champagne, Honourable Senators | Senate of Canada

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-16
    Communication number: 371-159407 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Claude Carrigan, Honourable Senators | Senate of Canada

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-16
    Communication number: 371-159405 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Patrick Brazeau, Honourable Senators | Senate of Canada

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-16
    Communication number: 371-159404 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pierre-Hugues Boisvenu, Honourable Senators | Senate of Canada

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-16
    Communication number: 371-159403 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean-Pierre Blackburn, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-16
    Communication number: 371-159402 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Josee Verner, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-16
    Communication number: 371-159400 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Denis Lebel, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-16
    Communication number: 371-159398 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bernard Genereux, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-16
    Communication number: 371-159395 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steven Blaney, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-16
    Communication number: 371-159392 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jacques Gourde, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-16
    Communication number: 371-159388 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Daniel Petit, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-16
    Communication number: 371-159386 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sylvie Boucher, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-16
    Communication number: 371-159384 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Martha Hall Findlay, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Industry, Intellectual Property, International Trade, Justice and Law Enforcement
    Communication date: 2010-10-04
    Posted date: 2010-11-16
    Communication number: 371-159376 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Scott Brison, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Industry, Intellectual Property, International Trade, Justice and Law Enforcement
    Communication date: 2010-10-04
    Posted date: 2010-11-16
    Communication number: 371-159375 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • John Gero, Ambassador and Permanent Representative | World Trade Organization (WTO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2010-09-29
    Posted date: 2010-10-16
    Communication number: 371-156808 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Scott Brison, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Industry, Intellectual Property, International Trade
    Communication date: 2010-09-21
    Posted date: 2010-10-16
    Communication number: 371-156807 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Richard Dicerni, Deputy Minister | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2010-08-27
    Posted date: 2010-09-16
    Communication number: 371-154633 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Glenda Yeates, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2010-08-27
    Posted date: 2010-09-16
    Communication number: 371-154632 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dr. Karen Dodds, PhD, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, International Relations, International Trade
    Communication date: 2010-08-18
    Posted date: 2010-09-16
    Communication number: 371-154630 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Elie Salibi, Policy Advisor | Industry Canada

    Subject Matter of the communication: Industry, Intellectual Property, International Trade
    Communication date: 2010-07-15
    Posted date: 2010-08-16
    Communication number: 371-153287 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Graham Howell, Senior Special Assistant | Health Canada (HC)

    Subject Matter of the communication: Health, Intellectual Property, International Trade
    Communication date: 2010-07-14
    Posted date: 2010-08-16
    Communication number: 371-153286 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Leah Canning, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Intellectual Property, International Trade
    Communication date: 2010-07-14
    Posted date: 2010-08-16
    Communication number: 371-153282 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Richard Dicerni, Deputy Minister | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2010-06-25
    Posted date: 2010-07-16
    Communication number: 371-151677 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ron Parker, Senior Assistant Deputy Minister | Industry Canada

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2010-06-23
    Posted date: 2010-07-16
    Communication number: 371-151678 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Robertson, Minister (Economic) | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2010-06-16
    Posted date: 2010-08-12
    Communication number: 371-153277 (amended from 371-151680) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2010-06-14
    Posted date: 2010-07-16
    Communication number: 371-151679 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ron Parker, Senior Assistant Deputy Minister | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2010-05-31
    Posted date: 2010-06-16
    Communication number: 371-150246 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Karen Dodds, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2010-05-31
    Posted date: 2010-06-16
    Communication number: 371-150245 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mike Storeshaw, Director of Communications | Finance Canada (FIN)

    Subject Matter of the communication: International Relations
    Communication date: 2010-05-20
    Posted date: 2010-06-16
    Communication number: 371-150244 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ken Benarek, Senior Policy Advisor | Justice Canada (JC)

    Subject Matter of the communication: Health, Intellectual Property, Justice and Law Enforcement
    Communication date: 2010-05-18
    Posted date: 2010-06-16
    Communication number: 371-150242 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Chief Trade Negotiator (Canada-European Union) | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2010-04-26
    Posted date: 2010-05-25
    Communication number: 371-147716 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Elie Salibi, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2010-04-20
    Posted date: 2010-05-25
    Communication number: 371-147715 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Darren Cunningham, Chief of Staff | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2010-03-25
    Posted date: 2010-04-16
    Communication number: 371-145637 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Elie Salibi, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2010-03-25
    Posted date: 2010-04-12
    Communication number: 371-145636 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Peter Van Loan, Minister of International Trade | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2010-03-10
    Posted date: 2010-04-16
    Communication number: 371-145635 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2010-02-10
    Posted date: 2010-03-16
    Communication number: 371-141979 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Leah Canning, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2010-02-05
    Posted date: 2010-03-16
    Communication number: 371-141978 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Scott Tessier, Chief of Staff | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2010-02-05
    Posted date: 2010-03-16
    Communication number: 371-141977 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Elie Salibi, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2010-02-04
    Posted date: 2010-03-16
    Communication number: 371-141975 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Coleen Volk, Associate Assistant Deputy Minister | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2010-01-21
    Posted date: 2010-02-16
    Communication number: 371-138495 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Karen Dodds, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Relations, International Trade
    Communication date: 2010-01-15
    Posted date: 2010-02-16
    Communication number: 371-138494 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Meena Ballantyne, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2009-12-09
    Posted date: 2010-01-16
    Communication number: 371-135675 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • William (Bill) King, Chief of Staff | Minister of Industry | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2009-12-08
    Posted date: 2010-01-16
    Communication number: 371-135654 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • John Gero, Ambassador & Permanent Reporesentative to the WTO | World Trade Organization (WTO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2009-11-09
    Posted date: 2009-12-16
    Communication number: 371-132889 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Daniel Jean, Deputy Secretary to the Cabinet, Privy Council Office | Office of the Deputy Secretary to the Cabinet (Operations) | Privy Council Office (PCO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2009-10-14
    Posted date: 2009-11-16
    Communication number: 371-127334 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Howard Alper, Chair | Industry Canada | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology, Taxation and Finance
    Communication date: 2009-09-29
    Posted date: 2009-10-14
    Communication number: 371-124620 (amended from 371-124619) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dr. Alain Beaudet, President | Canadian Institutes of Health Research (CIHR) | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2009-09-02
    Posted date: 2009-11-04
    Communication number: 371-124622 (amended from 371-124616) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Meena Ballantyne, Assistant Deputy Minister | Health Canada | Health Canada (HC)

    Subject Matter of the communication: Health, Intellectual Property, Science and Technology
    Communication date: 2009-09-01
    Posted date: 2009-10-16
    Communication number: 371-124614 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • William (Bill) King, Chief of Staff, Industry Canada. Ministry of Industry | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2009-08-14
    Posted date: 2009-09-16
    Communication number: 371-120437 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ron Parker, Senior Assistant Deputy Minister, Industry Canada | Industry Sector | Industry Canada

    Subject Matter of the communication: Industry, Intellectual Property, Science and Technology
    Communication date: 2009-08-13
    Posted date: 2009-09-16
    Communication number: 371-120436 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dr. Alain Beaudet, President, Canadian Institute of Health Research (CIHR) | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2009-08-03
    Posted date: 2009-09-16
    Communication number: 371-120435 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Elie Salibi, Policy Advisor | Industry Canada | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2009-07-22
    Posted date: 2009-08-17
    Communication number: 371-116956 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Elie Salibi, Policy Advisor | Industry Canada | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2009-07-15
    Posted date: 2009-08-17
    Communication number: 371-116954 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Cameron Adamson, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology, Small Business
    Communication date: 2009-06-04
    Posted date: 2009-07-16
    Communication number: 371-112414 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ken Bednarek, Senior Policy Advisor | Office of the Minister of Justice | Justice Canada (JC)

    Subject Matter of the communication: Health, Intellectual Property, Justice and Law Enforcement
    Communication date: 2009-06-02
    Posted date: 2009-07-16
    Communication number: 371-112375 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Elie Salibi, Policy Advisor to Minister of Industry | Industry Canada | Industry Canada

    Subject Matter of the communication: Industry, Intellectual Property
    Communication date: 2009-05-28
    Posted date: 2009-06-11
    Communication number: 371-108822 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Wilson, Director | Prime Minister's Office, Policy | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Intellectual Property, Science and Technology, Taxation and Finance
    Communication date: 2009-05-27
    Posted date: 2009-06-11
    Communication number: 371-108815 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tony Clement, Minister | Industry Canada | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology, Taxation and Finance
    Communication date: 2009-05-18
    Posted date: 2009-06-11
    Communication number: 371-108817 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Abby Hoffman, Assistant Deputy Minister | Health Canada | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2009-05-12
    Posted date: 2009-06-11
    Communication number: 371-108820 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Howard Alper, Chair | Industry Canada, Science Technology and Innovation Council Secretariat | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2009-05-07
    Posted date: 2009-06-11
    Communication number: 371-108814 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Susan Harper, Minister | Economic and Trade Policy | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2009-05-06
    Posted date: 2009-06-11
    Communication number: 371-108821 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chris Montgomery, Director, Parliamentary Affairs | Office of Leader of Government in the Senate | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Relations
    Communication date: 2009-05-06
    Posted date: 2009-06-11
    Communication number: 371-108819 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Don Stephenson, ADM | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology, Taxation and Finance
    Communication date: 2009-04-23
    Posted date: 2009-05-19
    Communication number: 371-106540 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Elie Salibi, Sr. Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology, Taxation and Finance
    Communication date: 2009-04-02
    Posted date: 2009-05-19
    Communication number: 371-106539 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Leah Canning, Policy Advisor | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology, Taxation and Finance
    Communication date: 2009-04-01
    Posted date: 2009-05-19
    Communication number: 371-106538 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bill King, Chief of Staff to Minister of Industry | Industry Canada

    Subject Matter of the communication: Industry, Intellectual Property, Science and Technology
    Communication date: 2009-03-26
    Posted date: 2009-04-15
    Communication number: 371-101122 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Meena Ballantyne, ADM | Health Canada (HC)

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2009-03-25
    Posted date: 2009-04-15
    Communication number: 371-101146 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Meena Ballantyne, ADM | Health Canada (HC)

    Subject Matter of the communication: Health, Intellectual Property, Science and Technology
    Communication date: 2009-03-20
    Posted date: 2009-04-15
    Communication number: 371-101125 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Susan Harper, Minister (Economics) | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Relations, International Trade
    Communication date: 2009-03-18
    Posted date: 2009-04-15
    Communication number: 371-101128 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Diane Ablonczy, Minister of State | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2009-03-04
    Posted date: 2009-04-15
    Communication number: 371-101142 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dr. Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2009-03-02
    Posted date: 2009-04-15
    Communication number: 371-101141 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Meena Ballantyne, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2009-02-13
    Posted date: 2009-03-13
    Communication number: 371-97333 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Phillip Welford, Chief of Staff, Minister of State for Science and Technology | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2009-02-10
    Posted date: 2009-03-13
    Communication number: 371-97345 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Benoit, Senoir Policy Advisor, Minister of International Trade | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2009-02-10
    Posted date: 2009-03-13
    Communication number: 371-97344 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ken Bednarek, Senior Policy Advisor, Minister of Justice | Justice Canada (JC)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2009-02-10
    Posted date: 2009-03-13
    Communication number: 371-97342 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Leah Canning, Policy Advisor | Health Canada (HC)

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property, Science and Technology, Taxation and Finance
    Communication date: 2009-01-22
    Posted date: 2009-02-13
    Communication number: 371-93594 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Benoit Violette, Senior Policy Advisor | Industry Canada

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property, Science and Technology, Taxation and Finance
    Communication date: 2009-01-22
    Posted date: 2009-02-13
    Communication number: 371-93581 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bill King, Chief of Staff to Minister Clement | Industry Canada

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property, Science and Technology, Taxation and Finance
    Communication date: 2009-01-22
    Posted date: 2009-02-13
    Communication number: 371-93576 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Benoit Violette, Senior Policy Advisor | Industry Canada

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2009-01-19
    Posted date: 2009-02-13
    Communication number: 371-93567 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Monalisa Ghose, Industry Development Officer | Industry Canada

    Subject Matter of the communication: Health, Intellectual Property, Science and Technology
    Communication date: 2009-01-12
    Posted date: 2009-02-13
    Communication number: 371-93640 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Audrey Turner, Manger, Industry Development | Industry Canada

    Subject Matter of the communication: Health, Intellectual Property, Science and Technology
    Communication date: 2009-01-12
    Posted date: 2009-02-13
    Communication number: 371-93638 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Cheryl Holden, Global Practice Lead, Life Sciences | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Intellectual Property, Science and Technology
    Communication date: 2009-01-12
    Posted date: 2009-02-13
    Communication number: 371-93636 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Leona Aglukkaq, MP | Members of the House of Commons

    Subject Matter of the communication: Health, Intellectual Property, Science and Technology
    Communication date: 2009-01-07
    Posted date: 2009-02-13
    Communication number: 371-93634 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Meena Ballantyne, ADM | Health Product and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2008-12-16
    Posted date: 2009-01-14
    Communication number: 371-90165 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Meena Ballantyne, ADM | Health Product and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2008-12-15
    Posted date: 2009-01-14
    Communication number: 371-90164 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2008-12-10
    Posted date: 2009-01-14
    Communication number: 371-90168 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David Rancourt, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Constitutional Issues, Health, Industry, Intellectual Property, Science and Technology, Taxation and Finance
    Communication date: 2008-12-04
    Posted date: 2009-01-14
    Communication number: 371-90172 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Amy Ringdahl, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Constitutional Issues, Health, Industry, Intellectual Property, Science and Technology, Taxation and Finance
    Communication date: 2008-12-04
    Posted date: 2009-01-14
    Communication number: 371-90170 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Benoit Violette, Policy Advisor | Industry Canada

    Subject Matter of the communication: Industry
    Communication date: 2008-11-27
    Posted date: 2008-12-10
    Communication number: 371-87552 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Minister Vic Toews, President of Treasury Board | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2008-11-17
    Posted date: 2008-12-10
    Communication number: 371-87550 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alain Baudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2008-11-14
    Posted date: 2008-12-10
    Communication number: 371-87549 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dr. Brien Benoit, Chairperson | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Consumer Issues, Health, Industry, Science and Technology
    Communication date: 2008-10-21
    Posted date: 2008-11-13
    Communication number: 371-85037 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Morris Rosenberg, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2008-08-28
    Posted date: 2008-09-12
    Communication number: 371-80547 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David Moloney, Assistant Deputy Minister | Industry Canada

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2008-08-25
    Posted date: 2008-09-12
    Communication number: 371-80546 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tony Clement, Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2008-08-17
    Posted date: 2008-09-12
    Communication number: 371-80545 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dani Shaw, Sr. Policy Advisor | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2008-08-15
    Posted date: 2008-09-12
    Communication number: 371-80543 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David Wells, Senior Policy Advisor | Fisheries and Oceans Canada (DFO)

    Subject Matter of the communication: Intellectual Property
    Communication date: 2008-08-14
    Posted date: 2008-09-12
    Communication number: 371-80541 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Derek Cummings, Director of Parliamentary Affairs | Natural Resources Canada (NRCan)

    Subject Matter of the communication: Intellectual Property
    Communication date: 2008-08-13
    Posted date: 2008-09-12
    Communication number: 371-80540 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dani Shaw, Sr. Policy Advisor | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2008-08-13
    Posted date: 2008-09-12
    Communication number: 371-80536 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Morris Rosenberg, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2008-08-01
    Posted date: 2008-09-12
    Communication number: 371-80535 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kera Wilkinson, Special Assistant to the Honourable Jay Hill | WHIP | House of Commons

    Subject Matter of the communication: Intellectual Property
    Communication date: 2008-07-31
    Posted date: 2008-08-14
    Communication number: 371-77295 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Morris Rosenberg, Deputy Minister | Deputy Minister's Office | Health Canada (HC)
    • Susan Vinet, ADM | Deputy Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2008-07-24
    Posted date: 2008-08-08
    Communication number: 371-76374 View monthly communication report
Date Modified: